<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599813477837</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599813477837</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Rhinological Manifestations of Women’s Health</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Saxby</surname><given-names>Alexander J.</given-names></name>
<degrees>MBChB, FRACS</degrees>
<xref ref-type="aff" rid="aff1-0194599813477837">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pace-Asciak</surname><given-names>Pia</given-names></name>
<degrees>MD, MASc</degrees>
<xref ref-type="aff" rid="aff1-0194599813477837">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dar Santos</surname><given-names>Rachelle C.</given-names></name>
<xref ref-type="aff" rid="aff1-0194599813477837">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chadha</surname><given-names>Neil K.</given-names></name>
<degrees>MBChB, FRCS</degrees>
<xref ref-type="aff" rid="aff1-0194599813477837">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kozak</surname><given-names>Frederick K.</given-names></name>
<degrees>MD, FRCSC</degrees>
<xref ref-type="aff" rid="aff1-0194599813477837">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599813477837"><label>1</label>Division of Otolaryngology, Head and Neck Surgery, Children’s and Women’s Hospital, Vancouver, BC, Canada</aff>
<author-notes>
<corresp id="corresp1-0194599813477837">Alexander J. Saxby, Division of Otolaryngology, Head and Neck Surgery, Children’s and Women’s Hospital, 4480 Oak St, Vancouver, BC, Canada V6H 3N1 Email: <email>alex_saxby@optusnet.com.au</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>148</volume>
<issue>5</issue>
<fpage>717</fpage>
<lpage>731</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>4</day>
<month>1</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>1</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599813477837">
<title>Objective</title>
<p>To systematically review the literature and appraise the evidence reporting the effects of women’s health, including pregnancy, postpartum, menstruation, oral contraception, menopause, and hormone replacement therapy, on common rhinological pathologies and nasal physiology.</p>
</sec>
<sec id="section2-0194599813477837">
<title>Data Sources</title>
<p>Systematic search strategy using MEDLINE (1966-2012) and EMBASE (1980-2012) databases.</p>
</sec>
<sec id="section3-0194599813477837">
<title>Review Methods</title>
<p>Title review, abstract screening, and then full paper analysis were undertaken by 2 authors independently. Level of evidence was graded according to the Oxford Centre of Evidence Based Medicine 2011 criteria and risk of bias assessment using the Jadad scale for randomized controlled trials and Newcastle-Ottawa Scale for cohort and case-controlled studies.</p>
</sec>
<sec id="section4-0194599813477837">
<title>Results</title>
<p>Over the 46 years analyzed, the search strategy produced 2904 titles. In total, 314 abstracts were screened, from which 192 full-text articles were evaluated, and 145 research papers met all the criteria for inclusion in the study. Overall, the available evidence was of low quality. Seventy percent of studies (102 of 145) were case reports or case series from which only limited conclusions can be drawn. Only 3% of the included papers (4 of 145) were randomized controlled studies. The remaining data were mainly of a prospective cohort design. Study heterogeneity in design and measured outcomes resulted in data synthesis being limited to a descriptive/exploratory review. Study findings are presented by women’s health category and then by rhinological manifestation with important clinical correlations highlighted.</p>
</sec>
<sec id="section5-0194599813477837">
<title>Conclusion</title>
<p>Physiological and hormonal changes occurring as a normal part of women’s health have an important influence on rhinological function and disease.</p>
</sec>
</abstract>
<kwd-group>
<kwd>nose diseases</kwd>
<kwd>rhinosinusitis</kwd>
<kwd>olfaction disorders</kwd>
<kwd>reproductive physiological phenomena</kwd>
<kwd>pregnancy complications</kwd>
<kwd>menopause</kwd>
<kwd>hormone replacement therapy</kwd>
<kwd>menstruation disturbances</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>There is a general perception that physiological and hormonal changes associated with various female conditions occurring during a woman’s life span may have an influence on rhinological function and disease. The aim of this review was to systematically identify and appraise the evidence for any such association. We present a descriptive and exploratory review intended to give a broad overview of what has been published rather than a hypothesis-testing undertaking.</p>
<p>Attention was focused on 3 main areas of women’s health: pregnancy and postpartum, menstruation and oral contraceptive pill (OCP), and menopause and hormone replacement therapy (HRT).</p>
<p>Results were analyzed according to their influence on 6 common rhinological conditions: olfaction, epistaxis, rhinitis, rhinosinusitis, nasal tumor, and inflammatory vasculitis.</p>
<p>The rationale for this review was to confirm or refute many frequently held beliefs with regard to how women’s health can affect common rhinological conditions to better tailor management protocols with the physiological changes of women taken into account.</p>
<sec id="section6-0194599813477837" sec-type="methods">
<title>Methods</title>
<sec id="section7-0194599813477837">
<title>Protocol and Registration</title>
<p>A study protocol was peer reviewed by the University of British Columbia Division of Otolaryngology Research Committee prior to any search being performed.</p>
</sec>
<sec id="section8-0194599813477837">
<title>Eligibility Criteria</title>
<p>A comprehensive search strategy using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)<sup><xref ref-type="bibr" rid="bibr1-0194599813477837">1</xref></sup> guidelines was developed to identify any peer-reviewed randomized controlled trials (RCTs), comparative studies, observational studies, case series, or case reports that fulfilled the following inclusion and exclusion criteria.</p>
<sec id="section9-0194599813477837">
<title>Inclusion Criteria</title>
<list id="list1-0194599813477837" list-type="bullet">
<list-item><p>Humans, female</p></list-item>
<list-item><p>Adult (age 19 years and older)</p></list-item>
<list-item><p>Primary research studies</p></list-item>
<list-item><p>English language</p></list-item>
<list-item><p>Publication date from January 1966 to October 2012 (MEDLINE) or January 1980 to October 2012 (EMBASE)</p></list-item>
<list-item><p>Original published studies related to rhinological pathology during pregnancy, postpartum, menstruation, menopause, or while taking oral contraceptives or hormone replacement therapy</p></list-item>
</list>
</sec>
<sec id="section10-0194599813477837">
<title>Exclusion Criteria</title>
<list id="list2-0194599813477837" list-type="bullet">
<list-item><p>Review articles with no primary research data</p></list-item>
<list-item><p>Animal models or in vitro studies</p></list-item>
<list-item><p>Pediatric studies (age 18 years and younger)</p></list-item>
<list-item><p>Pregnancy studies about neonatal outcomes rather than the maternal condition</p></list-item>
<list-item><p>Atopy studies with no direct data on nasal pathology</p></list-item>
<list-item><p>Olfaction studies related to hedonic outcomes</p></list-item>
<list-item><p>Olfaction studies related to congenital hyposmia syndromes such as Kallman’s syndrome</p></list-item>
</list>
<sec id="section11-0194599813477837">
<title>Justification for Eligibility Criteria</title>
<p>Given the large scope of this review in terms of broad inclusion criteria over a 46-year period, it was decided to limit the search to English-language primary studies on adults. Similarly, information gathering was confined to the study protocol as outlined, and further manual searches of the references and contacting of experts in the field were not a part of this exploratory review. Olfactory studies reporting hedonic outcomes were excluded due to these being primarily cortical in origin rather than of nasal etiology.</p>
</sec>
</sec>
</sec>
<sec id="section12-0194599813477837">
<title>Search Strategy</title>
<p>The above eligibility criteria were applied to 2 medical literature databases: MEDLINE (from January 1966 to October 2012) and EMBASE (from January 1980 to October 2012).</p>
<p>The following search strategy was chosen in consultation with a senior librarian with the College of Physicians and Surgeons of British Columbia: <italic>nose diseases</italic> [MeSH] OR <italic>granuloma</italic> [MeSH] OR <italic>Wegener granulomatosis</italic> [MeSH] OR <italic>pseudotumor</italic> OR <italic>rhinosinusitis</italic> OR <italic>olfaction disorders</italic> [MeSH] OR <italic>smell</italic> [MeSH] OR <italic>rhinitis</italic> AND <italic>reproductive physiological phenomena</italic> [MeSH] OR <italic>pregnancy complications</italic> [MeSH] OR <italic>menopause</italic> OR <italic>hormone replacement therapy</italic> [MeSH] OR <italic>estrogen replacement therapy</italic> [MeSH] OR <italic>gonadal steroid hormones</italic> [MeSH:NoExp] OR <italic>estradiol congeners</italic> [MeSH] OR <italic>progesterone congeners</italic> [MeSH] OR <italic>progestins</italic> [MESH] OR <italic>progestins [pharmacological action]</italic> OR <italic>estrogens [pharmacological action]</italic> OR <italic>estrogens</italic> [MeSH] OR <italic>hot flashes</italic> [MeSH] OR <italic>menstruation disturbances</italic> [MeSH] OR <italic>contraceptives, oral</italic> [MeSH] OR <italic>contraceptives, oral [pharmacological action]</italic>. Limits were set to humans, age 19 years and older, and English in both databases.</p>
</sec>
<sec id="section13-0194599813477837">
<title>Study Selection</title>
<p>Titles were initially screened to select abstracts that broadly met the inclusion criteria. Two authors screened all of the abstracts independently, and the combined selections were retrieved for full article appraisal. Independent review of each full journal article was undertaken by 2 authors. Duplications and articles not meeting the eligibility criteria after full review were excluded. The remaining studies formed the basis of the review from which data were extracted and risk of bias assessed.</p>
</sec>
<sec id="section14-0194599813477837">
<title>Data Extraction and Analysis</title>
<p>Identified research papers were collated according to the phase of women’s health and the rhinological manifestation under investigation. Key findings and data of interest were summarized for each article. Agreement between studies was noted and disparities explored. Because of the heterogeneous nature of the studies presented and lack of cohesion between methodologies, it was not appropriate to perform any meta-analysis of the data.</p>
</sec>
<sec id="section15-0194599813477837">
<title>Risk of Bias in Individual Studies</title>
<p>Each study was graded as to the level of evidence according to the 2011 criteria set by the Oxford Centre of Evidence Based Medicine.<sup><xref ref-type="bibr" rid="bibr2-0194599813477837">2</xref></sup> Risk of bias was assessed using established assessment criteria: the Jadad scale<sup><xref ref-type="bibr" rid="bibr3-0194599813477837">3</xref>
</sup> was applied to all randomized controlled trials and appraised the quality of randomization according to a 5-point scale. The Newcastle-Ottawa Scale<sup><xref ref-type="bibr" rid="bibr4-0194599813477837">4</xref></sup> (NOS) was applied to all cohort or case-controlled studies and scored the quality of the study out of a total of 9 points. We considered studies achieving scores of 8 to 9 to be low risk of bias, 6 to 7 medium risk, and scores &lt;6 high risk. All articles were independently assessed with these criteria, and in cases of disagreement, the lower of the two scores was used.</p>
</sec>
</sec>
<sec id="section16-0194599813477837" sec-type="results">
<title>Results</title>
<sec id="section17-0194599813477837">
<title>Study Selection</title>
<p>Over the 46 years analyzed, the search strategy produced 2904 titles; 314 abstracts were screened, from which 192 full-text articles were evaluated. In total, 145 research papers met all the criteria for inclusion in the study. <xref ref-type="fig" rid="fig1-0194599813477837"><bold>Figure 1</bold></xref> demonstrates the flow diagram of study selection with numbers of studies reviewed and excluded at each stage.</p>
<fig id="fig1-0194599813477837" position="float">
<label>Figure 1.</label>
<caption>
<p>PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)<sup><xref ref-type="bibr" rid="bibr1-0194599813477837">1</xref></sup> flow diagram demonstrating the number of records identified, included, and excluded and the reasons for exclusions.</p>
</caption>
<graphic xlink:href="10.1177_0194599813477837-fig1.tif"/>
</fig>
</sec>
<sec id="section18-0194599813477837">
<title>Overall Study Characteristics</title>
<p>Study heterogeneity in terms of design and measured outcomes resulted in data extraction being limited to a narrative description of the findings. Meta-analysis was not appropriate for this particular systematic review. <xref ref-type="fig" rid="fig2-0194599813477837"><bold>Figure 2</bold></xref> charts the number of studies pertinent to each aspect of the study according to the level of evidence.</p>
<fig id="fig2-0194599813477837" position="float">
<label>Figure 2.</label>
<caption>
<p>Bar charts demonstrating volume of research for each female health subgroup organized by level of evidence based on the Oxford Centre for Evidence Based Medicine 2011 criteria.<sup><xref ref-type="bibr" rid="bibr2-0194599813477837">2</xref></sup> HRT, hormone replacement therapy; OCP, oral contraceptive pill.</p>
</caption>
<graphic xlink:href="10.1177_0194599813477837-fig2.tif"/>
</fig>
</sec>
<sec id="section19-0194599813477837">
<title>Overall Risk of Bias within Studies</title>
<p>Overall, the evidence was of low quality. Seventy percent of studies (102 of 145) were case reports or case series (level 4 evidence) from which only limited conclusions can be drawn. Only 3% of the included articles (4 of 145) were randomized controlled studies<sup><xref ref-type="bibr" rid="bibr5-0194599813477837">5</xref><xref ref-type="bibr" rid="bibr6-0194599813477837"/><xref ref-type="bibr" rid="bibr7-0194599813477837"/>-<xref ref-type="bibr" rid="bibr8-0194599813477837">8</xref></sup> (level 2 evidence). The remaining data were mainly of a prospective cohort design.</p>
<p>When assessed by the NOS,<sup><xref ref-type="bibr" rid="bibr4-0194599813477837">4</xref></sup> the median score was 6 of 9 (mean 6.4/9), which equates to a high to medium risk of bias in most cases. Studies in general lacked adequate patient numbers and demonstrated poor controlling for factors known to affect rhinological outcome such as smoking history.</p>
</sec>
</sec>
<sec id="section20-0194599813477837">
<title>Analysis of Studies</title>
<sec id="section21-0194599813477837">
<title>Pregnancy and Postpartum</title>
<sec id="section22-0194599813477837">
<title>Olfaction</title>
<p>The largest study to report on olfactory sensitivity during the pregnant period came from the National Geographic Smell Survey,<sup><xref ref-type="bibr" rid="bibr9-0194599813477837">9</xref></sup> which surveyed a total of 290,838 women, of whom 13,610 were pregnant. It used a combination of self-reported “sense of smell” plus a scratch-and-sniff card within the magazine. Comparison of discriminatory ability was only significant for 1 of 6 tested odorants, with the pregnant group performing better. Pregnant women rated their sense of smell lower than the nonpregnant group (<italic>P</italic> &lt; .0001) (level 2 evidence, NOS score 7/9).</p>
<p>Contrary results were seen in 2 smaller studies, both of which found pregnant women self-rated their olfactory sensitivity as higher than nonpregnant controls.<sup><xref ref-type="bibr" rid="bibr10-0194599813477837">10</xref>,<xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref></sup> Of 100 pregnant women asked to rate change with the onset of their pregnancy, 61% reported increased sensitivity, 38% no change, and only 1 woman stated a worsening of sense of smell<sup><xref ref-type="bibr" rid="bibr10-0194599813477837">10</xref></sup> (level 3 evidence, NOS score 8/9). A similarly designed study<sup><xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref></sup> also reported higher self-rated sensitivity in the pregnant cohort (<italic>P</italic> &lt; .001) (level 3 evidence, NOS score 7/9). Further details of these studies are represented in <xref ref-type="table" rid="table1-0194599813477837"><bold>Table 1</bold></xref>.</p>
<table-wrap id="table1-0194599813477837" position="float">
<label>Table 1.</label>
<caption>
<p>Olfaction and Pregnancy</p>
</caption>
<graphic alternate-form-of="table1-0194599813477837" xlink:href="10.1177_0194599813477837-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Year</th>
<th align="center">n</th>
<th align="center">Evidence<sup><xref ref-type="table-fn" rid="table-fn2-0194599813477837">a</xref></sup> (NOS Score)</th>
<th align="center">Methodology</th>
<th align="center">Results</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6" valign="top">Self-reported olfactory sensitivity</td>
</tr>
<tr>
<td valign="top"> Gilbert and Wysocki<sup><xref ref-type="bibr" rid="bibr9-0194599813477837">9</xref></sup></td>
<td valign="top">1991</td>
<td valign="top">290,838</td>
<td valign="top">Level 2 (7)</td>
<td valign="top">National Geographic Smell Study. Self-rated sense of smell (grade 1-5) on questionnaire incorporated in <italic>National Geographic</italic> magazine.</td>
<td valign="top">Pregnant group rated their sense of smell lower than the nonpregnant group (<italic>P</italic> &lt; .0001).</td>
</tr>
<tr>
<td valign="top"> Cameron<sup><xref ref-type="bibr" rid="bibr10-0194599813477837">10</xref></sup></td>
<td valign="top">2007</td>
<td valign="top">100</td>
<td valign="top">Level 3 (8)</td>
<td valign="top">20 per trimester with 2 control groups (postpartum and nonpregnant). Self-rated sense of smell (grade 1-7) at test time and retrospectively (prepregnancy).</td>
<td valign="top">Pregnant groups rated sensitivity higher compared with their prepregnancy rating and with nonpregnant controls (<italic>P</italic> &lt; .0001). Greatest effect in first-trimester group (<italic>P</italic> = .01).</td>
</tr>
<tr>
<td valign="top"> Ochsenbein-Kolble et al<sup><xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref></sup></td>
<td valign="top">2007</td>
<td valign="top">84</td>
<td valign="top">Level 3 (7)</td>
<td valign="top">38 pregnant and 46 nonpregnant women. Self-rated olfactory sensitivity with 10-cm VAS.</td>
<td valign="top">Pregnant group rated themselves as more sensitive to odors than did controls (<italic>P</italic> &lt; .001).</td>
</tr>
<tr>
<td colspan="6" valign="top">Objectively measured olfactory threshold</td>
</tr>
<tr>
<td valign="top"> Kolble et al<sup><xref ref-type="bibr" rid="bibr12-0194599813477837">12</xref></sup></td>
<td valign="top">2001</td>
<td valign="top">112</td>
<td valign="top">Level 3 (8)</td>
<td valign="top">Serial <italic>n</italic>-butanol dilution test. 53 pregnant and 59 nonpregnant women. Only studied first trimester.</td>
<td valign="top">No significant difference between pregnant and nonpregnant controls.</td>
</tr>
<tr>
<td valign="top"> Wohlgemuth et al<sup><xref ref-type="bibr" rid="bibr13-0194599813477837">13</xref></sup></td>
<td valign="top">2008</td>
<td valign="top">93</td>
<td valign="top">Level 3 (8)</td>
<td valign="top">Serial <italic>n</italic>-butanol dilution test. 26 nulliparous, 26 uniparous, and 41 multiparous participants.</td>
<td valign="top">No significant difference between any groups.</td>
</tr>
<tr>
<td valign="top"> Ochsenbein-Kolble et al<sup><xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref></sup></td>
<td valign="top">2007</td>
<td valign="top">84</td>
<td valign="top">Level 3 (7)</td>
<td valign="top">Serial <italic>n</italic>-butanol dilution test. 38 pregnant women analyzed at first, second, and third trimesters and postpartum plus 46 nonpregnant controls.</td>
<td valign="top">Decreased threshold (increased sensitivity) seen in pregnant group compared with controls in third trimester (<italic>P</italic> = .001) and postpartum (<italic>P</italic> &lt; .001).</td>
</tr>
<tr>
<td colspan="6" valign="top">Objectively measured olfactory identification and discrimination</td>
</tr>
<tr>
<td valign="top"> Kolble et al<sup><xref ref-type="bibr" rid="bibr12-0194599813477837">12</xref></sup></td>
<td valign="top">2001</td>
<td valign="top">112</td>
<td valign="top">Level 3 (8)</td>
<td valign="top">Sniffin’ Stick Test Kit.<sup><xref ref-type="table-fn" rid="table-fn3-0194599813477837">b</xref></sup> 53 pregnant and 59 nonpregnant women. Only studied first trimester.</td>
<td valign="top">No significant difference between pregnant and nonpregnant controls.</td>
</tr>
<tr>
<td valign="top"> Cameron<sup><xref ref-type="bibr" rid="bibr10-0194599813477837">10</xref></sup></td>
<td valign="top">2007</td>
<td valign="top">100</td>
<td valign="top">Level 3 (8)</td>
<td valign="top">UPSIT. 20 patients per trimester with 2 control groups (postpartum and nonpregnant).</td>
<td valign="top">No significant difference between any groups.</td>
</tr>
<tr>
<td valign="top"> Wohlgemuth et al<sup><xref ref-type="bibr" rid="bibr13-0194599813477837">13</xref></sup></td>
<td valign="top">2008</td>
<td valign="top">93</td>
<td valign="top">Level 3 (8)</td>
<td valign="top">Sniffin’ Stick Test Kit.<sup><xref ref-type="table-fn" rid="table-fn3-0194599813477837">b</xref></sup> 26 nulliparous, 26 uniparous, and 41 multiparous participants.</td>
<td valign="top">No significant difference between any groups.</td>
</tr>
<tr>
<td valign="top"> Ochsenbein-Kolble et al<sup><xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref></sup></td>
<td valign="top">2007</td>
<td valign="top">84</td>
<td valign="top">Level 3 (7)</td>
<td valign="top">Sniffin’ Stick Test Kit.<sup><xref ref-type="table-fn" rid="table-fn3-0194599813477837">b</xref></sup> 38 pregnant women assessed at first, second, and third trimesters and postpartum plus 46 nonpregnant controls.</td>
<td valign="top">No significant difference between pregnant and nonpregnant groups at any stage.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599813477837">
<p>Abbreviations: UPSIT, University of Pennsylvania Smell Identification Test; VAS, visual analog scale.</p>
</fn>
<fn id="table-fn2-0194599813477837">
<label>a</label>
<p>Level of evidence graded according to the Oxford Centre for Evidence Based Medicine 2011 criteria.<sup><xref ref-type="bibr" rid="bibr2-0194599813477837">2</xref></sup> NOS score represents the Newcastle-Ottawa Scale of study quality<sup><xref ref-type="bibr" rid="bibr4-0194599813477837">4</xref></sup> (graded 0-9).</p>
</fn>
<fn id="table-fn3-0194599813477837">
<label>b</label>
<p>Sniffin’ Stick Test Kit (Heinrich Burghart Elektro-und Feinmechanik GmbH, Wedel, Germany).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Olfactory threshold was examined with serial <italic>n</italic>-butanol dilutions in 3 separate studies<sup><xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref><xref ref-type="bibr" rid="bibr12-0194599813477837"/>-<xref ref-type="bibr" rid="bibr13-0194599813477837">13</xref></sup> with mixed results. One study found no significant difference between pregnant and nonpregnant groups<sup><xref ref-type="bibr" rid="bibr12-0194599813477837">12</xref></sup> (level 3 evidence, NOS score 8/9), whereas another showed a significant decrease in threshold in the third trimester continuing into the postpartum period<sup><xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref></sup> (<italic>P</italic> = .001) (level 3 evidence, NOS score 7/9). The third studied whether previous pregnancy and multiparity made a long-lasting influence on threshold and again found no statistical difference<sup><xref ref-type="bibr" rid="bibr13-0194599813477837">13</xref></sup> (level 3 evidence, NOS score 8/9).</p>
<p>Identification and discrimination were assessed with the Sniffin’ Stick Test Kit (Heinrich Burghart Elektro-und Feinmechanik GmbH, Wedel, Germany)<sup><xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref><xref ref-type="bibr" rid="bibr12-0194599813477837"/>-<xref ref-type="bibr" rid="bibr13-0194599813477837">13</xref></sup> and the University of Pennsylvania Smell Identification Test (UPSIT).<sup><xref ref-type="bibr" rid="bibr10-0194599813477837">10</xref></sup> No significant difference between pregnant and control groups was reported in any of these studies (level 3 evidence). A number of other studies employed poor methodologies, limiting the validity of their results.<sup><xref ref-type="bibr" rid="bibr14-0194599813477837">14</xref><xref ref-type="bibr" rid="bibr15-0194599813477837"/><xref ref-type="bibr" rid="bibr16-0194599813477837"/>-<xref ref-type="bibr" rid="bibr17-0194599813477837">17</xref></sup></p>
<p>Cortical responses to olfactory presentations (chemosomatosensory event related potentials or CSERPs) failed to demonstrate a difference between pregnant and nonpregnant controls<sup><xref ref-type="bibr" rid="bibr18-0194599813477837">18</xref></sup> (level 3 evidence, NOS score 6/9).</p>
</sec>
<sec id="section23-0194599813477837">
<title>Epistaxis</title>
<p>There were a number of case studies of epistaxis occurring during pregnancy,<sup><xref ref-type="bibr" rid="bibr19-0194599813477837">19</xref><xref ref-type="bibr" rid="bibr20-0194599813477837"/><xref ref-type="bibr" rid="bibr21-0194599813477837"/><xref ref-type="bibr" rid="bibr22-0194599813477837"/><xref ref-type="bibr" rid="bibr23-0194599813477837"/>-<xref ref-type="bibr" rid="bibr24-0194599813477837">24</xref></sup> but several of these were complicated by other contributing comorbid diagnoses such as idiopathic thrombocytopenic purpura<sup><xref ref-type="bibr" rid="bibr24-0194599813477837">24</xref></sup> or known coagulopathy.<sup><xref ref-type="bibr" rid="bibr22-0194599813477837">22</xref></sup> One large questionnaire-based study<sup><xref ref-type="bibr" rid="bibr25-0194599813477837">25</xref></sup> of 1470 pregnancies, which controlled for confounding hemorrhagic conditions, demonstrated a prevalence of 20.3% compared with 6.2% in a nonpregnant control group (<italic>P</italic> &lt; .001) (level 2 evidence, NOS score 8/9). Epistaxis was defined as 1 or more “active” nosebleeds during the pregnancy or a similar incidence during the preceding year in the age-matched nonpregnant controls.</p>
</sec>
<sec id="section24-0194599813477837">
<title>Rhinitis</title>
<sec id="section25-0194599813477837">
<title>Pregnancy rhinitis</title>
<p>Pregnancy rhinitis was poorly defined between studies such that estimation of the true prevalence was difficult to gauge. Bende and Gredmark<sup><xref ref-type="bibr" rid="bibr26-0194599813477837">26</xref></sup> performed a large prospective longitudinal study of 2264 pregnant women assessing the likelihood of experiencing daily nasal obstruction for at least 3 weeks at various stages in the pregnancy. They found an increasing prevalence with gestational age, with an overall 65% experiencing nasal obstruction at some stage.</p>
<p>The second largest study looked at 599 pregnancies<sup><xref ref-type="bibr" rid="bibr27-0194599813477837">27</xref></sup> and found a prevalence of 22% using a definition of chronic nasal obstruction not attributable to upper respiratory tract infection or allergy occurring during the last 6 weeks of pregnancy and resolving within 2 weeks postpartum. This definition was common to 6 other studies,<sup><xref ref-type="bibr" rid="bibr28-0194599813477837">28</xref><xref ref-type="bibr" rid="bibr29-0194599813477837"/><xref ref-type="bibr" rid="bibr30-0194599813477837"/><xref ref-type="bibr" rid="bibr31-0194599813477837"/><xref ref-type="bibr" rid="bibr32-0194599813477837"/>-<xref ref-type="bibr" rid="bibr33-0194599813477837">33</xref></sup> giving a mean prevalence of 19.6% with good interstudy agreement (level 2 evidence). See <xref ref-type="table" rid="table2-0194599813477837"><bold>Table 2</bold></xref> for further details of these studies.</p>
<table-wrap id="table2-0194599813477837" position="float">
<label>Table 2.</label>
<caption>
<p>Prevalence of Pregnancy Rhinitis</p>
</caption>
<graphic alternate-form-of="table2-0194599813477837" xlink:href="10.1177_0194599813477837-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Year</th>
<th align="center">n</th>
<th align="center">Evidence<sup><xref ref-type="table-fn" rid="table-fn5-0194599813477837">a</xref></sup> (NOS Score)</th>
<th align="center">Definition</th>
<th align="center">Methodology</th>
<th align="center">Prevalence</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top">Bende and Gredmark<sup><xref ref-type="bibr" rid="bibr26-0194599813477837">26</xref></sup></td>
<td valign="top">1999</td>
<td valign="top">2264</td>
<td valign="top">Level 2 (8)</td>
<td valign="top">“Daily nasal stuffiness for 3 weeks’ duration”</td>
<td valign="top">Prospective longitudinal study over 1 year. Self-reported nasal stuffiness</td>
<td valign="top">Prevalence increases with gestational age: 27% (12 wk), 37% (20 wk), 40% (30 wk), and 42% (36 wk). Overall 65% reported “nasal stuffiness”</td>
</tr>
<tr>
<td valign="top">Ellegard et al<sup><xref ref-type="bibr" rid="bibr27-0194599813477837">27</xref></sup></td>
<td valign="top">2000</td>
<td valign="top">599</td>
<td valign="top">Level 2 (8)</td>
<td valign="top">“Nasal congestion occurring in the last 6 weeks of pregnancy with no other attributable etiology, resolving within 2 weeks post partum”</td>
<td valign="top">Prospective cohort study with nasal congestion assessed by history</td>
<td valign="top">22% (95% CI, 19%-26%). Higher incidence in smokers (37% vs 22%) (<italic>P</italic> = .02). Odds ratio, 1.7 (95% CI, 1.1-2.5). Asthma/hay fever: no correlation</td>
</tr>
<tr>
<td valign="top">Shushan et al<sup><xref ref-type="bibr" rid="bibr32-0194599813477837">32</xref></sup></td>
<td valign="top">1999</td>
<td valign="top">109</td>
<td valign="top">Level 2 (7)</td>
<td valign="top">“Nasal obstruction and rhinorrhea appearing during pregnancy, lasting at least 2 months and disappearing post partum”</td>
<td valign="top">Prospective cohort of women in active labor and 1 month postpartum, assessed by subjective nasal symptoms and anterior rhinoscopy</td>
<td valign="top">10/109 (9%)</td>
</tr>
<tr>
<td valign="top">Ellegard and Karlsson<sup><xref ref-type="bibr" rid="bibr28-0194599813477837">28</xref></sup></td>
<td valign="top">1999</td>
<td valign="top">23</td>
<td valign="top">Level 3 (6)</td>
<td valign="top">“Nasal congestion occurring in the last 6 weeks of pregnancy with no other attributable etiology, resolving within 2 weeks post partum”</td>
<td valign="top">Prospective cohort study using subjective symptom score (0-4) and objective nasal peak flow 4 times during pregnancy and postpartum</td>
<td valign="top">5/23 (22%)</td>
</tr>
<tr>
<td valign="top">Sobol et al<sup><xref ref-type="bibr" rid="bibr36-0194599813477837">36</xref></sup></td>
<td valign="top">2001</td>
<td valign="top">61</td>
<td valign="top">Level 3 (5)</td>
<td valign="top">No clear definition</td>
<td valign="top">Prospective longitudinal study of 33 women (28 nonpregnant controls) using VAS for nasal symptoms during first, second, and third trimesters</td>
<td valign="top">“Nasal congestion” in 61%, 55%, and 55% of the pregnant cohort during the first, second, and third trimesters, respectively, compared with 33% of the control group</td>
</tr>
<tr>
<td valign="top">Mabry<sup><xref ref-type="bibr" rid="bibr35-0194599813477837">35</xref></sup></td>
<td valign="top">1986</td>
<td valign="top">66</td>
<td valign="top">Level 4 (4)</td>
<td valign="top">Loose definition of “constant or frequent nasal congestion” at any time during the pregnancy</td>
<td valign="top">Retrospective questionnaire given during the third trimester (ninth month of pregnancy)</td>
<td valign="top">12/66 (18%)</td>
</tr>
<tr>
<td valign="top">Turnbull et al<sup><xref ref-type="bibr" rid="bibr34-0194599813477837">34</xref></sup></td>
<td valign="top">1996</td>
<td valign="top">160</td>
<td valign="top">Level 4 (2)</td>
<td valign="top">Poorly defined. “Nasal congestion that was pregnancy related”</td>
<td valign="top">In recruitment for a therapeutic device trial, pregnant women were screened for nasal symptoms.</td>
<td valign="top">34/160 (21%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0194599813477837">
<p>Abbreviations: CI, confidence interval; VAS, visual analog scale.</p>
</fn>
<fn id="table-fn5-0194599813477837">
<label>a</label>
<p>Level of evidence graded according to the Oxford Centre for Evidence Based Medicine 2011 criteria.<sup><xref ref-type="bibr" rid="bibr2-0194599813477837">2</xref></sup> NOS score represents the Newcastle-Ottawa Scale of study quality<sup><xref ref-type="bibr" rid="bibr4-0194599813477837">4</xref></sup> (graded 0-9).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Various other durations were used to define the condition in the remaining studies, including 2 weeks,<sup><xref ref-type="bibr" rid="bibr6-0194599813477837">6</xref></sup> 10 days,<sup><xref ref-type="bibr" rid="bibr5-0194599813477837">5</xref></sup> and “any complaint of nasal stuffiness,”<sup><xref ref-type="bibr" rid="bibr34-0194599813477837">34</xref>,<xref ref-type="bibr" rid="bibr35-0194599813477837">35</xref></sup> and no clear definition was reported in several studies.<sup><xref ref-type="bibr" rid="bibr36-0194599813477837">36</xref><xref ref-type="bibr" rid="bibr37-0194599813477837"/>-<xref ref-type="bibr" rid="bibr38-0194599813477837">38</xref></sup></p>
<p>Pregnancy rhinitis was generally reported as a separate entity from allergic rhinitis. A well-designed cohort study of 165 pregnant women<sup><xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref></sup> compared those with and without pregnancy rhinitis and found no difference in overall seroatopy or hyperreactivity to histamine, concluding that pregnancy rhinitis is not an allergic manifestation. Several other studies also reported no correlation between pregnancy rhinitis and prepregnancy allergic rhinitis.<sup><xref ref-type="bibr" rid="bibr27-0194599813477837">27</xref>,<xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref>,<xref ref-type="bibr" rid="bibr35-0194599813477837">35</xref></sup></p>
<p>No correlation was found between pregnancy rhinitis and asthma,<sup><xref ref-type="bibr" rid="bibr27-0194599813477837">27</xref>,<xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref></sup> parity,<sup><xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref>,<xref ref-type="bibr" rid="bibr35-0194599813477837">35</xref></sup> age,<sup><xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref></sup> child’s sex,<sup><xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref></sup> or estrogen/progesterone levels.<sup><xref ref-type="bibr" rid="bibr31-0194599813477837">31</xref></sup> One study found a significantly higher proportion of smokers in women with pregnancy rhinitis (<italic>P</italic> = .003)<sup><xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref></sup> (level 3 evidence, NOS score 6/9).</p>
<p>Correlation of these subjective assessments of nasal obstruction with objective measures such a mucociliary flow<sup><xref ref-type="bibr" rid="bibr30-0194599813477837">30</xref></sup> or anterior rhinoscopy<sup><xref ref-type="bibr" rid="bibr32-0194599813477837">32</xref></sup> was poor. One study assessed the histological changes in pregnant women complaining of nasal symptoms<sup><xref ref-type="bibr" rid="bibr38-0194599813477837">38</xref></sup> and found changes similar to those seen in allergic rhinitis.</p>
<p>In terms of treatment for pregnancy rhinitis, there were 2 small but well-designed single-center placebo-controlled double-blinded studies with appropriate outcome measures.<sup><xref ref-type="bibr" rid="bibr5-0194599813477837">5</xref>,<xref ref-type="bibr" rid="bibr6-0194599813477837">6</xref></sup> The first trialed an oral decongestant (phenylpropanolamine) vs placebo,<sup><xref ref-type="bibr" rid="bibr6-0194599813477837">6</xref></sup> and the second used topical nasal steroid (fluticasone) vs placebo.<sup><xref ref-type="bibr" rid="bibr5-0194599813477837">5</xref></sup> Neither showed a significant difference in outcome whether by subjective symptom score or objective nasal peak flow or rhinostereometry (level 2 evidence, Jadad score 4/5 in both studies).</p>
</sec>
<sec id="section26-0194599813477837">
<title>Allergic rhinitis</title>
<p>According to a large study of 700 pregnant women by Abraham et al,<sup><xref ref-type="bibr" rid="bibr39-0194599813477837">39</xref></sup> the incidence of physician-diagnosed allergic rhinitis is 15.5% (95% confidence interval [CI], 12.5-18.0). This agrees with another cohort of 626 pregnant women<sup><xref ref-type="bibr" rid="bibr40-0194599813477837">40</xref></sup> in which 93 (14.8%) had physician-diagnosed “hay fever.” These figures correlate well with reported prevalence rates for the general population.<sup><xref ref-type="bibr" rid="bibr41-0194599813477837">41</xref></sup> A recent Japanese cross-sectional study of 1745 pregnant women<sup><xref ref-type="bibr" rid="bibr42-0194599813477837">42</xref></sup> found a slightly higher prevalence of 25.9% but did not differentiate pregnancy rhinitis from allergic rhinitis. It reported a possible correlation to meat intake<sup><xref ref-type="bibr" rid="bibr43-0194599813477837">43</xref></sup> and smoking<sup><xref ref-type="bibr" rid="bibr42-0194599813477837">42</xref></sup> in 2 separate articles.</p>
<p>A large longitudinal study by Harris et al<sup><xref ref-type="bibr" rid="bibr44-0194599813477837">44</xref></sup> in 2004 looked at whether multiparity reduced maternal atopy. The authors reported a significant trend toward loss of nasal allergy with increasing parity. By interviewing women over a 7-year period, they found that 32% of women who had reported hay fever symptoms at their first pregnancy no longer reported such symptoms at their second pregnancy. This number rose to 42% if they had 2 intervening pregnancies and 60% if pregnant 3 or more times (level 3 evidence, NOS score 6/9).</p>
<p>The question of whether allergic rhinitis symptoms worsen with pregnancy has not been directly studied, but an article looking primarily at asthma control during pregnancy found a high concordance between asthma exacerbation and nasal symptoms.<sup><xref ref-type="bibr" rid="bibr45-0194599813477837">45</xref></sup></p>
<p>Two studies addressed treatment of established allergic rhinitis during pregnancy.<sup><xref ref-type="bibr" rid="bibr7-0194599813477837">7</xref>,<xref ref-type="bibr" rid="bibr46-0194599813477837">46</xref></sup> Garavello et al<sup><xref ref-type="bibr" rid="bibr7-0194599813477837">7</xref></sup> evaluated saline irrigations in a randomized design and found both subjective scores and objective measurement of nasal resistance with rhinomanometry were significantly reduced in the treatment arm (level 2 evidence; Jadad score 3/5). Numbers were small but well matched. A possible bias included the unrestricted use of oral antihistamines. The topic of desensitization during pregnancy was studied in an article from 1966, but long-term outcomes were not reported.<sup><xref ref-type="bibr" rid="bibr46-0194599813477837">46</xref></sup></p>
</sec>
<sec id="section27-0194599813477837">
<title>Rhinosinusitis</title>
<p>The reviewed literature contained only case studies (level 4 evidence) with regard to the effect of pregnancy on rhinosinusitis.<sup><xref ref-type="bibr" rid="bibr47-0194599813477837">47</xref><xref ref-type="bibr" rid="bibr48-0194599813477837"/><xref ref-type="bibr" rid="bibr49-0194599813477837"/><xref ref-type="bibr" rid="bibr50-0194599813477837"/><xref ref-type="bibr" rid="bibr51-0194599813477837"/><xref ref-type="bibr" rid="bibr52-0194599813477837"/><xref ref-type="bibr" rid="bibr53-0194599813477837"/>-<xref ref-type="bibr" rid="bibr54-0194599813477837">54</xref></sup> The majority reported complications, but as to what contribution the pregnant state made on the disease progression was confounded by other comorbidities in most cases. There were 3 case reports of invasive fungal rhinosinusitis,<sup><xref ref-type="bibr" rid="bibr49-0194599813477837">49</xref>,<xref ref-type="bibr" rid="bibr52-0194599813477837">52</xref>,<xref ref-type="bibr" rid="bibr53-0194599813477837">53</xref></sup> but again 2 had immunosuppressive comorbidities (diabetic ketoacidosis<sup><xref ref-type="bibr" rid="bibr53-0194599813477837">53</xref></sup> and aplastic anemia<sup><xref ref-type="bibr" rid="bibr49-0194599813477837">49</xref></sup>). The third case<sup><xref ref-type="bibr" rid="bibr52-0194599813477837">52</xref></sup> involved fulminant <italic>Drechslera spicifera</italic> rhinosinusitis in an immunocompetent 21-year-old that presented in the first trimester and rapidly progressed. The authors postulate that the rapid growth was due in part to the hormonal conditions of the pregnancy.</p>
</sec>
</sec>
<sec id="section28-0194599813477837">
<title>Nasal Tumor</title>
<sec id="section29-0194599813477837">
<title>Pyogenic granuloma</title>
<p>Pyogenic granuloma was by far the most commonly reported nasal tumor occurring during pregnancy, with 19 isolated case reports or case series.<sup><xref ref-type="bibr" rid="bibr55-0194599813477837">55</xref><xref ref-type="bibr" rid="bibr56-0194599813477837"/><xref ref-type="bibr" rid="bibr57-0194599813477837"/><xref ref-type="bibr" rid="bibr58-0194599813477837"/><xref ref-type="bibr" rid="bibr59-0194599813477837"/><xref ref-type="bibr" rid="bibr60-0194599813477837"/><xref ref-type="bibr" rid="bibr61-0194599813477837"/><xref ref-type="bibr" rid="bibr62-0194599813477837"/><xref ref-type="bibr" rid="bibr63-0194599813477837"/><xref ref-type="bibr" rid="bibr64-0194599813477837"/><xref ref-type="bibr" rid="bibr65-0194599813477837"/><xref ref-type="bibr" rid="bibr66-0194599813477837"/><xref ref-type="bibr" rid="bibr67-0194599813477837"/><xref ref-type="bibr" rid="bibr68-0194599813477837"/><xref ref-type="bibr" rid="bibr69-0194599813477837"/><xref ref-type="bibr" rid="bibr70-0194599813477837"/><xref ref-type="bibr" rid="bibr71-0194599813477837"/><xref ref-type="bibr" rid="bibr72-0194599813477837"/>-<xref ref-type="bibr" rid="bibr73-0194599813477837">73</xref></sup> Almost all cases involved excision of the lesion under local anesthetic with approximately three-quarters of the case studies performing this during the pregnancy and the remainder in the postpartum period. Recurrence was reported in 3 of the 16 cases excised during pregnancy (18.8%). None of the 6 cases of excision within the postpartum period reported recurrence (level 4 evidence).</p>
</sec>
<sec id="section30-0194599813477837">
<title>Other nasal tumors</title>
<p>There were 6 case reports of nasal tumors occurring during pregnancy: Burkitt lymphoma,<sup><xref ref-type="bibr" rid="bibr74-0194599813477837">74</xref></sup> midline lethal granuloma,<sup><xref ref-type="bibr" rid="bibr75-0194599813477837">75</xref></sup> angiofibroma,<sup><xref ref-type="bibr" rid="bibr76-0194599813477837">76</xref></sup> eccrine poroma,<sup><xref ref-type="bibr" rid="bibr77-0194599813477837">77</xref></sup> olfactory neuroblastoma,<sup><xref ref-type="bibr" rid="bibr78-0194599813477837">78</xref></sup> and giant cell granuloma.<sup><xref ref-type="bibr" rid="bibr79-0194599813477837">79</xref></sup> Several of these described rapid growth patterns during the pregnancy attributed to the altered hormonal and immunological conditions<sup><xref ref-type="bibr" rid="bibr74-0194599813477837">74</xref>,<xref ref-type="bibr" rid="bibr76-0194599813477837">76</xref>,<xref ref-type="bibr" rid="bibr77-0194599813477837">77</xref>,<xref ref-type="bibr" rid="bibr79-0194599813477837">79</xref></sup> (level 4 evidence).</p>
<p>Two cases of metastatic choriocarcinoma to the nasal cavity were reported.<sup><xref ref-type="bibr" rid="bibr80-0194599813477837">80</xref>,<xref ref-type="bibr" rid="bibr81-0194599813477837">81</xref></sup> Both occurred in nulliparous women, but one had undergone spontaneous abortion 6 months prior<sup><xref ref-type="bibr" rid="bibr80-0194599813477837">80</xref></sup> and the other had a hydatidiform pregnancy 1 year prior<sup><xref ref-type="bibr" rid="bibr81-0194599813477837">81</xref></sup> to the diagnosis of their nasal metastatic disease. Neither was pregnant at the time of the nasal mass.</p>
</sec>
<sec id="section31-0194599813477837">
<title>Vasculitis</title>
<p>Studies involving systemic vasculitis and pregnancy were again solely case report based (level 4 evidence). There were multiple reports of both Wegener’s granulomatosis (WG) and Churg-Strauss vasculitis (CS) occurring de novo during pregnancy<sup><xref ref-type="bibr" rid="bibr82-0194599813477837">82</xref><xref ref-type="bibr" rid="bibr83-0194599813477837"/><xref ref-type="bibr" rid="bibr84-0194599813477837"/><xref ref-type="bibr" rid="bibr85-0194599813477837"/><xref ref-type="bibr" rid="bibr86-0194599813477837"/><xref ref-type="bibr" rid="bibr87-0194599813477837"/><xref ref-type="bibr" rid="bibr88-0194599813477837"/><xref ref-type="bibr" rid="bibr89-0194599813477837"/><xref ref-type="bibr" rid="bibr90-0194599813477837"/><xref ref-type="bibr" rid="bibr91-0194599813477837"/><xref ref-type="bibr" rid="bibr92-0194599813477837"/>-<xref ref-type="bibr" rid="bibr93-0194599813477837">93</xref></sup> or the postpartum period.<sup><xref ref-type="bibr" rid="bibr94-0194599813477837">94</xref><xref ref-type="bibr" rid="bibr95-0194599813477837"/><xref ref-type="bibr" rid="bibr96-0194599813477837"/><xref ref-type="bibr" rid="bibr97-0194599813477837"/><xref ref-type="bibr" rid="bibr98-0194599813477837"/>-<xref ref-type="bibr" rid="bibr99-0194599813477837">99</xref></sup></p>
<p>For patients with a previous established diagnosis of systemic vasculitis subsequently becoming pregnant, approximately half of the case reports (48%) documented a flare-up of the disease,<sup><xref ref-type="bibr" rid="bibr97-0194599813477837">97</xref>,<xref ref-type="bibr" rid="bibr99-0194599813477837">99</xref><xref ref-type="bibr" rid="bibr100-0194599813477837"/><xref ref-type="bibr" rid="bibr101-0194599813477837"/><xref ref-type="bibr" rid="bibr102-0194599813477837"/><xref ref-type="bibr" rid="bibr103-0194599813477837"/><xref ref-type="bibr" rid="bibr104-0194599813477837"/><xref ref-type="bibr" rid="bibr105-0194599813477837"/><xref ref-type="bibr" rid="bibr106-0194599813477837"/><xref ref-type="bibr" rid="bibr107-0194599813477837"/><xref ref-type="bibr" rid="bibr108-0194599813477837"/>-<xref ref-type="bibr" rid="bibr109-0194599813477837">109</xref></sup> and half were not exacerbated during the time of the pregnancy<sup><xref ref-type="bibr" rid="bibr98-0194599813477837">98</xref>,<xref ref-type="bibr" rid="bibr99-0194599813477837">99</xref>,<xref ref-type="bibr" rid="bibr110-0194599813477837">110</xref><xref ref-type="bibr" rid="bibr111-0194599813477837"/><xref ref-type="bibr" rid="bibr112-0194599813477837"/><xref ref-type="bibr" rid="bibr113-0194599813477837"/><xref ref-type="bibr" rid="bibr114-0194599813477837"/><xref ref-type="bibr" rid="bibr115-0194599813477837"/>-<xref ref-type="bibr" rid="bibr116-0194599813477837">116</xref></sup> (level 4 evidence).</p>
</sec>
</sec>
</sec>
<sec id="section32-0194599813477837">
<title>Menstruation and Oral Contraceptive Pill</title>
<p>There were no studies relating the menstrual cycle or OCP to rhinosinusitis, nasal tumors, or systemic vasculitis.</p>
<sec id="section33-0194599813477837">
<title>Olfaction</title>
<p>Studies of olfaction with menstruation were generally poorly designed with small numbers and heterogeneity in testing methods.</p>
<p>Threshold analysis used either the Fortunato-Niccolini olfactometer<sup><xref ref-type="bibr" rid="bibr117-0194599813477837">117</xref>,<xref ref-type="bibr" rid="bibr118-0194599813477837">118</xref></sup> or dilutional testing of a single vapor: 2-furaldehyde,<sup><xref ref-type="bibr" rid="bibr119-0194599813477837">119</xref></sup> exaltolide,<sup><xref ref-type="bibr" rid="bibr120-0194599813477837">120</xref></sup> cyclopentadecanolide,<sup><xref ref-type="bibr" rid="bibr121-0194599813477837">121</xref></sup> or amyl acetate.<sup><xref ref-type="bibr" rid="bibr122-0194599813477837">122</xref></sup> These studies universally found an increased sensitivity (lowest threshold) at ovulation<sup><xref ref-type="bibr" rid="bibr117-0194599813477837">117</xref><xref ref-type="bibr" rid="bibr118-0194599813477837"/><xref ref-type="bibr" rid="bibr119-0194599813477837"/><xref ref-type="bibr" rid="bibr120-0194599813477837"/><xref ref-type="bibr" rid="bibr121-0194599813477837"/>-<xref ref-type="bibr" rid="bibr122-0194599813477837">122</xref></sup> (level 2 evidence). A number of other studies had such small patient numbers or poor design that the validity of any conclusions was questionable.<sup><xref ref-type="bibr" rid="bibr123-0194599813477837">123</xref><xref ref-type="bibr" rid="bibr124-0194599813477837"/>-<xref ref-type="bibr" rid="bibr125-0194599813477837">125</xref></sup></p>
<p>Cortical responses to olfactory presentations (CSERPs) did not show the same peak at ovulation but suffered from a sample size of only 6 patients<sup><xref ref-type="bibr" rid="bibr126-0194599813477837">126</xref></sup> (level 4 evidence).</p>
<p>There were no studies of olfactory identification or discrimination ability with regard to menstruation or OCP.</p>
</sec>
<sec id="section34-0194599813477837">
<title>Epistaxis</title>
<p>There were no studies on epistaxis and the menstrual cycle and only 1 case report of a woman taking the OCP for 6 months who then had an episode of severe epistaxis.<sup><xref ref-type="bibr" rid="bibr127-0194599813477837">127</xref></sup> A case series of 4 patients with hereditary hemorrhagic telangiectasia all taking the OCP<sup><xref ref-type="bibr" rid="bibr128-0194599813477837">128</xref></sup> postulated that it may have increased the frequency of epistaxis, but the findings were poorly supported by any substantial data (level 4 evidence).</p>
</sec>
<sec id="section35-0194599813477837">
<title>Rhinitis</title>
<p>A large single-cohort study of 4077 menstruating women found an increased prevalence of allergic rhinitis with irregular menstruation vs regular menstruation (28.8% vs 23.6%; odds ratio, 1.29; 95% CI, 1.05-1.57)<sup><xref ref-type="bibr" rid="bibr129-0194599813477837">129</xref></sup> (level 2 evidence). However, diagnosis of allergic rhinitis was by subjective response to a single question regarding “hay fever or nasal allergies” on a postal questionnaire.</p>
<p>Association was also demonstrated with premenstrual syndrome (PMS) in a moderate-sized cohort study in which the prevalence of physician-diagnosed allergic rhinitis was compared in patients diagnosed with PMS with age-matched female controls.<sup><xref ref-type="bibr" rid="bibr130-0194599813477837">130</xref></sup> The group with a diagnosis of PMS had a 29.5% prevalence of allergic rhinitis compared with only 15.2% of women without PMS (odds ratio, 2.33; 95% CI, 1.13-4.86; <italic>P</italic> &lt; .02) (level 2 evidence).</p>
<p>Although 8 articles<sup><xref ref-type="bibr" rid="bibr117-0194599813477837">117</xref><xref ref-type="bibr" rid="bibr118-0194599813477837"/>-<xref ref-type="bibr" rid="bibr119-0194599813477837">119</xref>,<xref ref-type="bibr" rid="bibr131-0194599813477837">131</xref><xref ref-type="bibr" rid="bibr132-0194599813477837"/><xref ref-type="bibr" rid="bibr133-0194599813477837"/><xref ref-type="bibr" rid="bibr134-0194599813477837"/>-<xref ref-type="bibr" rid="bibr135-0194599813477837">135</xref></sup> studied the effects of the menstrual cycle on nasal physiology, most were small, and a variety of methodologies were used. The largest study (reported separately in the rhinology and reproductive literature) employed rhinomanometry and found no significant difference between phases of the menstrual cycle<sup><xref ref-type="bibr" rid="bibr117-0194599813477837">117</xref>,<xref ref-type="bibr" rid="bibr118-0194599813477837">118</xref></sup> (level 2 evidence, NOS score 9/9). Other smaller studies using rhinomanometry had mixed results, 1 also finding no significance<sup><xref ref-type="bibr" rid="bibr131-0194599813477837">131</xref></sup> but 2 finding increased nasal resistance at mid-cycle.<sup><xref ref-type="bibr" rid="bibr119-0194599813477837">119</xref>,<xref ref-type="bibr" rid="bibr132-0194599813477837">132</xref></sup> Acoustic rhinometry failed to show a statistically significant difference in nasal volume during the menstrual cycle<sup><xref ref-type="bibr" rid="bibr132-0194599813477837">132</xref>,<xref ref-type="bibr" rid="bibr133-0194599813477837">133</xref>,<xref ref-type="bibr" rid="bibr135-0194599813477837">135</xref></sup> (level 3 evidence). Nasal peak flow suggested significantly increased resistance at menstruation, which correlated well with subjective scoring<sup><xref ref-type="bibr" rid="bibr134-0194599813477837">134</xref></sup> (level 3 evidence, NOS score 8/9). <xref ref-type="table" rid="table3-0194599813477837"><bold>Table 3</bold></xref> outlines the detail of these studies.</p>
<table-wrap id="table3-0194599813477837" position="float">
<label>Table 3.</label>
<caption>
<p>Menstrual Cycle and Nasal Physiology</p>
</caption>
<graphic alternate-form-of="table3-0194599813477837" xlink:href="10.1177_0194599813477837-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">Year</th>
<th align="center">n</th>
<th align="center">Evidence<sup><xref ref-type="table-fn" rid="table-fn6-0194599813477837">a</xref></sup> (NOS Score)</th>
<th align="center">Methodology</th>
<th align="center">Results</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top">Grillo et al<sup><xref ref-type="bibr" rid="bibr118-0194599813477837">118</xref></sup></td>
<td valign="top">2001</td>
<td valign="top">64</td>
<td valign="top">Level 2 (9)</td>
<td valign="top">RM measured at 3 phases (follicular, ovulation, and luteal). Same data also presented in Caruso et al<sup><xref ref-type="bibr" rid="bibr117-0194599813477837">117</xref></sup></td>
<td valign="top">No significant difference</td>
</tr>
<tr>
<td valign="top">Ellegard and Karlsson<sup><xref ref-type="bibr" rid="bibr134-0194599813477837">134</xref></sup></td>
<td valign="top">1994</td>
<td valign="top">27</td>
<td valign="top">Level 3 (8)</td>
<td valign="top">Twice-daily nPEF and subjective nasal obstruction score (grade 0-4) over 3 months (27 women) or 6 months (14 women)</td>
<td valign="top">nPEF lowest at menstruation (<italic>P</italic> = .001). nPEF and subjective score correlate well (<italic>R</italic> = 0.98).</td>
</tr>
<tr>
<td valign="top">Paulsson et al<sup><xref ref-type="bibr" rid="bibr135-0194599813477837">135</xref></sup></td>
<td valign="top">1997</td>
<td valign="top">26</td>
<td valign="top">Level 3 (5)</td>
<td valign="top">Part 1: twice-daily nPEF over 2 months (26 women). Part 2: subjective nasal obstruction (10-cm VAS) and AR measured twice (premenstrual/during menstruation) (8 women)</td>
<td valign="top">Tendency toward increased nasal patency before menstruation but did not reach statistical significance</td>
</tr>
<tr>
<td valign="top">Doty et al<sup><xref ref-type="bibr" rid="bibr119-0194599813477837">119</xref></sup></td>
<td valign="top">1981</td>
<td valign="top">15</td>
<td valign="top">Level 4 (3)</td>
<td valign="top">Cottle Nasal Flow Pneumotachometric Transducer System (ICS, Chicago, Illinois) measurements every 48 hours for 2 cycles. 9 women with 6 controls (3 men and 3 women using OCP)</td>
<td valign="top">Nasal airflow lowest at ovulation (<italic>P</italic> &lt; .05)</td>
</tr>
<tr>
<td valign="top">Driver et al<sup><xref ref-type="bibr" rid="bibr131-0194599813477837">131</xref></sup></td>
<td valign="top">2005</td>
<td valign="top">11</td>
<td valign="top">Level 4 (3)</td>
<td valign="top">RM measured as a part of a sleep study performed twice (follicular phase and then luteal phase)</td>
<td valign="top">No significant difference</td>
</tr>
<tr>
<td valign="top">Philpott et al<sup><xref ref-type="bibr" rid="bibr132-0194599813477837">132</xref></sup></td>
<td valign="top">2004</td>
<td valign="top">10</td>
<td valign="top">Level 4 (3)</td>
<td valign="top">AR, nPEF, RM, and MCT measured twice (menstruation and mid-cycle)</td>
<td valign="top">At ovulation, RM (increased resistance) and MCT (decreased time) were significant (<italic>P</italic> &lt; .05).</td>
</tr>
<tr>
<td valign="top">Haeggstrom et al<sup><xref ref-type="bibr" rid="bibr133-0194599813477837">133</xref></sup></td>
<td valign="top">2000</td>
<td valign="top">8</td>
<td valign="top">Level 4 (3)</td>
<td valign="top">AR and RS measurements at menstruation, ovulation, and luteal phase</td>
<td valign="top">No significant difference</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0194599813477837">
<label>a</label>
<p>Level of evidence graded according to the Oxford Centre for Evidence Based Medicine 2011 criteria.<sup><xref ref-type="bibr" rid="bibr2-0194599813477837">2</xref></sup> NOS score represents the Newcastle-Ottawa Scale of study quality<sup><xref ref-type="bibr" rid="bibr4-0194599813477837">4</xref></sup> (graded 0-9).</p>
</fn>
<fn id="table-fn7-0194599813477837">
<p>Abbreviations: AR, acoustic rhinometry; MCT, mucociliary clearance time; nPEF, nasal peak expiratory flow; OCP, oral contraceptive pill; RM, rhinomanometry; RS, rhinostereometry; VAS, visual analog scale.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>One small longitudinal study of 11 women looked at various nasal physiological parameters before and during use of the OCP and found no significant changes in nasal peak flow, acoustic rhinometry, rhinomanometry, or mucociliary flow<sup><xref ref-type="bibr" rid="bibr136-0194599813477837">136</xref></sup> (level 4 evidence). This was complemented by another small cohort study that found no difference in rhinomanometry measurements between women taking the OCP and matched controls<sup><xref ref-type="bibr" rid="bibr137-0194599813477837">137</xref></sup> (level 2 evidence, NOS score 5/9).</p>
<p>Two histological studies of the nasal mucosa attributed changes to the varying levels of estrogen.<sup><xref ref-type="bibr" rid="bibr138-0194599813477837">138</xref>,<xref ref-type="bibr" rid="bibr139-0194599813477837">139</xref></sup> Smear cytology showed increased cornified cells during the follicular phase, which mirrored changes seen in menopause and prepubertal conditions.<sup><xref ref-type="bibr" rid="bibr138-0194599813477837">138</xref></sup> Symptomatic patients using the OCP had changes of squamous metaplasia, glandular hyperplasia, interstitial edema, and fibrous tissue deposition.<sup><xref ref-type="bibr" rid="bibr139-0194599813477837">139</xref></sup></p>
</sec>
</sec>
<sec id="section36-0194599813477837">
<title>Menopause and Hormone Replacement Therapy</title>
<p>There were no studies found that analyzed menopause or HRT and rhinosinusitis, nasal tumors, or systemic vasculitis.</p>
<sec id="section37-0194599813477837">
<title>Olfaction</title>
<p>In a cohort study of 62 postmenopausal women, half of whom had self-selected to take HRT, no significant difference was reported in threshold detection or UPSIT-measured discrimination<sup><xref ref-type="bibr" rid="bibr140-0194599813477837">140</xref></sup> (level 3 evidence, NOS score 7/9). However, a longitudinal study of 47 women, using the Fortunato-Niccolini olfactometer to measure olfactory threshold before and during HRT use, did show a significant improvement in sensitivity after 6 cycles of HRT (<italic>P</italic> &lt; .001)<sup><xref ref-type="bibr" rid="bibr141-0194599813477837">141</xref></sup> (level 2 evidence, NOS score 9/9).</p>
<p>Deems et al<sup><xref ref-type="bibr" rid="bibr142-0194599813477837">142</xref></sup> looked at a large cohort presenting with olfactory dysfunction, including 414 women, of whom 99 were postmenopausal. Performance of pre- vs postmenopause subgroups was not reported, but they did speculate that HRT may preserve olfactory function because only 4 of the 99 menopausal women were on HRT, which is statistically fewer than reported in other studies (4% vs 16%; <italic>P</italic> &lt; .001). Performance of the HRT group demonstrated no difference in threshold detection but an increased performance on UPSIT (<italic>P</italic> &lt; .005) (level 2 evidence, NOS score 6/9). This suffers from the fact that the HRT arm had only 4 patients.</p>
<p>Several studies whose primary outcomes related to other pathologies such as Alzheimer’s dementia<sup><xref ref-type="bibr" rid="bibr143-0194599813477837">143</xref>,<xref ref-type="bibr" rid="bibr144-0194599813477837">144</xref></sup> or schizophrenia<sup><xref ref-type="bibr" rid="bibr145-0194599813477837">145</xref></sup> indirectly reported information with regard to the role of menopause or HRT on olfaction. Of these studies, no significant difference was seen in threshold<sup><xref ref-type="bibr" rid="bibr144-0194599813477837">144</xref></sup> or UPSIT-measured discrimination<sup><xref ref-type="bibr" rid="bibr143-0194599813477837">143</xref></sup> with patients taking HRT. With regard to menopause, extrapolating the data from menopause subgroups of a study of schizophrenia patients<sup><xref ref-type="bibr" rid="bibr145-0194599813477837">145</xref></sup> found lower UPSIT-measured discrimination scores in the postmenopausal groups (<italic>P</italic> = .01), which correlated well with measured estradiol assays.</p>
</sec>
<sec id="section38-0194599813477837">
<title>Epistaxis</title>
<p>A large French study of 2197 mature-aged women,<sup><xref ref-type="bibr" rid="bibr146-0194599813477837">146</xref></sup> of whom 74% were postmenopausal, reported a yearly incidence of epistaxis of 7.6%, which required medical attention in &lt;4% of cases. This figure did not control for those on HRT (69%) plus may have been biased by the entire cohort being enrolled in a trial of an oral antioxidant supplement that could perceivably affect nasal bleeding.</p>
<p>A small longitudinal study of patients diagnosed with hereditary hemorrhagic telangiectasia before and after 6 months’ use of HRT found a significant decrease in Sadich epistaxis scores following HRT use<sup><xref ref-type="bibr" rid="bibr147-0194599813477837">147</xref></sup> (level 3 evidence, NOS score 5/9).</p>
</sec>
<sec id="section39-0194599813477837">
<title>Rhinitis</title>
<p>Several large questionnaire-style cross-sectional studies looked at the incidence of rhinitis symptoms in mature-aged women. In the French antioxidant supplement cohort mentioned above, the authors also studied rhinitis symptoms.<sup><xref ref-type="bibr" rid="bibr146-0194599813477837">146</xref></sup> They found that a statistically higher proportion of postmenopausal patients reported at least 1 symptom of rhinitis in a 1-year period (71.3% vs 64.1%; odds ratio, 1.47; 95% CI, 1.2-1.9), whereas no significant difference was evident in those taking HRT (level 2 evidence).</p>
<p>A UK questionnaire-based survey of 3724 women<sup><xref ref-type="bibr" rid="bibr148-0194599813477837">148</xref></sup> found significantly higher reporting of rhinitis symptoms in the postmenopausal subgroup (odds ratio, 1.28; 95% CI, 1.07-1.76). Increased reporting was also seen in HRT vs non-HRT use, but this only reached significance in the age group older than 55 years (odds ratio, 1.58; 95% CI, 1.11-2.23) (level 2 evidence).</p>
<p>A similar Scandinavian survey of 1527 women,<sup><xref ref-type="bibr" rid="bibr149-0194599813477837">149</xref></sup> of whom 424 were postmenopausal and not taking HRT, found no difference in the reporting of “hay fever or nasal allergy” symptoms (level 2 evidence). They noted an increased reporting of such symptoms in those using HRT (odds ratio, 1.47; 95% CI, 1.14-1.88), but the non-HRT arm contained all the <italic>pre</italic>menopausal patients, which might have affected the outcome.</p>
<p>Studies using objective measures of nasal function in patients on HRT all suffered from low patient numbers.<sup><xref ref-type="bibr" rid="bibr141-0194599813477837">141</xref>,<xref ref-type="bibr" rid="bibr150-0194599813477837">150</xref>,<xref ref-type="bibr" rid="bibr151-0194599813477837">151</xref></sup> One randomized nonblinded placebo-controlled approach<sup><xref ref-type="bibr" rid="bibr149-0194599813477837">149</xref></sup> had treatment arms of only 12 patients but reported significant changes in both subjective score and mucociliary transit time for the HRT group (<italic>P</italic> &lt; .01 and <italic>P</italic> &lt; .05, respectively). Rhinomanometry-measured airway resistance remained unchanged (level 3 evidence, Jadad score 4/5). Two longitudinal studies of patients before and during HRT had opposing conclusions. Caruso et al<sup><xref ref-type="bibr" rid="bibr141-0194599813477837">141</xref></sup> found improvement in nasal resistance following HRT use (<italic>P</italic> &lt; .001) in a cohort of 47 menopausal women (level 2 evidence, NOS score 9/9), whereas a second smaller study of 20 patients,<sup><xref ref-type="bibr" rid="bibr151-0194599813477837">151</xref></sup> which in addition measured nasal peak flow, acoustic rhinometry, and mucociliary flow, found no significant difference in any variable (level 3 evidence, NOS score 5/9). However, controlling of confounding factors was poor, and they employed a variable end point ranging from 77 to 195 days of HRT.</p>
</sec>
</sec>
</sec>
<sec id="section40-0194599813477837" sec-type="discussion">
<title>Discussion</title>
<p>The effect of pregnancy on olfaction appears limited. Pregnant women’s perception that their sensitivity changes, which varied between studies as to whether it increased<sup><xref ref-type="bibr" rid="bibr10-0194599813477837">10</xref>,<xref ref-type="bibr" rid="bibr11-0194599813477837">11</xref></sup> or decreased,<sup><xref ref-type="bibr" rid="bibr9-0194599813477837">9</xref></sup> was not supported by objective studies of olfactory threshold or discrimination, which tended to show no significant difference between pregnant and nonpregnant olfactory performance<sup><xref ref-type="bibr" rid="bibr10-0194599813477837">10</xref><xref ref-type="bibr" rid="bibr11-0194599813477837"/><xref ref-type="bibr" rid="bibr12-0194599813477837"/>-<xref ref-type="bibr" rid="bibr13-0194599813477837">13</xref></sup> (level 2 evidence).</p>
<p>The effect of menstruation appeared more conclusive, with several studies in agreement that olfactory sensitivity peaks at ovulation<sup><xref ref-type="bibr" rid="bibr117-0194599813477837">117</xref><xref ref-type="bibr" rid="bibr118-0194599813477837"/><xref ref-type="bibr" rid="bibr119-0194599813477837"/><xref ref-type="bibr" rid="bibr120-0194599813477837"/><xref ref-type="bibr" rid="bibr121-0194599813477837"/>-<xref ref-type="bibr" rid="bibr122-0194599813477837">122</xref></sup> (level 2 evidence).</p>
<p>The belief that HRT may preserve olfactory sensitivity was not convincingly demonstrated in the literature, with roughly equal numbers of studies reporting opposing conclusions in this regard. However, the 1 well-designed longitudinal study with the lowest risk of bias did suggest that thresholds improved after establishment of HRT<sup><xref ref-type="bibr" rid="bibr141-0194599813477837">141</xref></sup> (level 2 evidence).</p>
<p>The widely held view that epistaxis is more frequent during pregnancy was demonstrated in at least 1 well-designed study,<sup><xref ref-type="bibr" rid="bibr25-0194599813477837">25</xref></sup> whereas the effects of the menstrual cycle or oral contraceptive were not conclusive. Menopause again demonstrated a rise in prevalence but more modest than that seen in pregnancy<sup><xref ref-type="bibr" rid="bibr146-0194599813477837">146</xref></sup> (level 2 evidence).</p>
<p>The existence of a form of rhinitis specific to pregnancy was reported in a number of studies, but there was a lack of cohesion in terms of the definition of what qualifies such a diagnosis. Given the common definition of late pregnancy onset (last 6 weeks) of persistent rhinitis in a previously asymptomatic patient that resolves within 2 weeks postpartum, the prevalence would appear to be approximately 1 in 5 pregnancies<sup><xref ref-type="bibr" rid="bibr28-0194599813477837">28</xref><xref ref-type="bibr" rid="bibr29-0194599813477837"/><xref ref-type="bibr" rid="bibr30-0194599813477837"/><xref ref-type="bibr" rid="bibr31-0194599813477837"/>-<xref ref-type="bibr" rid="bibr32-0194599813477837">32</xref></sup> (level 2 evidence). Other than a tentative link with smoking,<sup><xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref></sup> there were no other obvious risk factors.<sup><xref ref-type="bibr" rid="bibr27-0194599813477837">27</xref>,<xref ref-type="bibr" rid="bibr29-0194599813477837">29</xref>,<xref ref-type="bibr" rid="bibr31-0194599813477837">31</xref>,<xref ref-type="bibr" rid="bibr35-0194599813477837">35</xref></sup> It is interesting that no improved outcome was demonstrated with the use of topical nasal steroids<sup><xref ref-type="bibr" rid="bibr5-0194599813477837">5</xref></sup> (level 2 evidence), but it is worth remembering that all cases, by definition, resolve following birth.</p>
<p>Allergic rhinitis appears no more prevalent in pregnancy than in nonpregnant populations<sup><xref ref-type="bibr" rid="bibr39-0194599813477837">39</xref><xref ref-type="bibr" rid="bibr40-0194599813477837"/>-<xref ref-type="bibr" rid="bibr41-0194599813477837">41</xref></sup> but may reduce with multiparity.<sup><xref ref-type="bibr" rid="bibr44-0194599813477837">44</xref></sup> There were some data to support that irregular menstruation and premenopausal syndrome are associated with an increased prevalence of rhinitis,<sup><xref ref-type="bibr" rid="bibr129-0194599813477837">129</xref>,<xref ref-type="bibr" rid="bibr130-0194599813477837">130</xref></sup> but objective data on the influence of the cycle itself on nasal physiology were mixed.<sup><xref ref-type="bibr" rid="bibr117-0194599813477837">117</xref><xref ref-type="bibr" rid="bibr118-0194599813477837"/>-<xref ref-type="bibr" rid="bibr119-0194599813477837">119</xref>,<xref ref-type="bibr" rid="bibr131-0194599813477837">131</xref><xref ref-type="bibr" rid="bibr132-0194599813477837"/><xref ref-type="bibr" rid="bibr133-0194599813477837"/>-<xref ref-type="bibr" rid="bibr134-0194599813477837">134</xref></sup> The use of OCP does not appear to affect nasal airflow,<sup><xref ref-type="bibr" rid="bibr136-0194599813477837">136</xref>,<xref ref-type="bibr" rid="bibr137-0194599813477837">137</xref></sup> but studies had a high risk of bias. The effect of menopause on nasal allergic symptoms was not conclusive, with 3 large population studies disagreeing.<sup><xref ref-type="bibr" rid="bibr146-0194599813477837">146</xref>,<xref ref-type="bibr" rid="bibr148-0194599813477837">148</xref>,<xref ref-type="bibr" rid="bibr149-0194599813477837">149</xref></sup> Objective measures of nasal airflow with HRT use displayed similarly mixed outcomes and were inconclusive.<sup><xref ref-type="bibr" rid="bibr141-0194599813477837">141</xref>,<xref ref-type="bibr" rid="bibr150-0194599813477837">150</xref>,<xref ref-type="bibr" rid="bibr151-0194599813477837">151</xref></sup></p>
<p>The literature contains several interesting reports of pregnancies affected by complications of rhinosinusitis, but the influence of the pregnancy itself on the clinical course of the disease is speculative at best, with most cases having other contributing factors.<sup><xref ref-type="bibr" rid="bibr47-0194599813477837">47</xref><xref ref-type="bibr" rid="bibr48-0194599813477837"/><xref ref-type="bibr" rid="bibr49-0194599813477837"/><xref ref-type="bibr" rid="bibr50-0194599813477837"/><xref ref-type="bibr" rid="bibr51-0194599813477837"/><xref ref-type="bibr" rid="bibr52-0194599813477837"/><xref ref-type="bibr" rid="bibr53-0194599813477837"/>-<xref ref-type="bibr" rid="bibr54-0194599813477837">54</xref></sup></p>
<p>The general conception that pyogenic granuloma is the commonest nasal mass found in pregnancy was certainly supported by the large number of case reports in the literature.<sup><xref ref-type="bibr" rid="bibr55-0194599813477837">55</xref><xref ref-type="bibr" rid="bibr56-0194599813477837"/><xref ref-type="bibr" rid="bibr57-0194599813477837"/><xref ref-type="bibr" rid="bibr58-0194599813477837"/><xref ref-type="bibr" rid="bibr59-0194599813477837"/><xref ref-type="bibr" rid="bibr60-0194599813477837"/><xref ref-type="bibr" rid="bibr61-0194599813477837"/><xref ref-type="bibr" rid="bibr62-0194599813477837"/><xref ref-type="bibr" rid="bibr63-0194599813477837"/><xref ref-type="bibr" rid="bibr64-0194599813477837"/><xref ref-type="bibr" rid="bibr65-0194599813477837"/><xref ref-type="bibr" rid="bibr66-0194599813477837"/><xref ref-type="bibr" rid="bibr67-0194599813477837"/><xref ref-type="bibr" rid="bibr68-0194599813477837"/><xref ref-type="bibr" rid="bibr69-0194599813477837"/><xref ref-type="bibr" rid="bibr70-0194599813477837"/><xref ref-type="bibr" rid="bibr71-0194599813477837"/><xref ref-type="bibr" rid="bibr72-0194599813477837"/>-<xref ref-type="bibr" rid="bibr73-0194599813477837">73</xref></sup> Inferences can be made from this with regard to the recurrence rate after excision, which appears to approximate 1 in 5 (level 4 evidence). There is tentative evidence to support the notion that excision in the postpartum period pertains to a lower likelihood of recurrence (level 4 evidence).</p>
<p>Multiple studies reported de novo occurrence of systemic vasculitis presenting with nasal manifestations during pregnancy and postpartum<sup><xref ref-type="bibr" rid="bibr82-0194599813477837">82</xref><xref ref-type="bibr" rid="bibr83-0194599813477837"/><xref ref-type="bibr" rid="bibr84-0194599813477837"/><xref ref-type="bibr" rid="bibr85-0194599813477837"/><xref ref-type="bibr" rid="bibr86-0194599813477837"/><xref ref-type="bibr" rid="bibr87-0194599813477837"/><xref ref-type="bibr" rid="bibr88-0194599813477837"/><xref ref-type="bibr" rid="bibr89-0194599813477837"/><xref ref-type="bibr" rid="bibr90-0194599813477837"/><xref ref-type="bibr" rid="bibr91-0194599813477837"/><xref ref-type="bibr" rid="bibr92-0194599813477837"/><xref ref-type="bibr" rid="bibr93-0194599813477837"/><xref ref-type="bibr" rid="bibr94-0194599813477837"/><xref ref-type="bibr" rid="bibr95-0194599813477837"/><xref ref-type="bibr" rid="bibr96-0194599813477837"/><xref ref-type="bibr" rid="bibr97-0194599813477837"/><xref ref-type="bibr" rid="bibr98-0194599813477837"/>-<xref ref-type="bibr" rid="bibr99-0194599813477837">99</xref></sup> such that this differential should always be kept in mind when assessing the pregnant patient with atypical nasal symptoms. The influence of pregnancy on established cases of systemic vasculitis was not clear, but a significant proportion did experience exacerbations.<sup><xref ref-type="bibr" rid="bibr97-0194599813477837">97</xref>,<xref ref-type="bibr" rid="bibr99-0194599813477837">99</xref><xref ref-type="bibr" rid="bibr100-0194599813477837"/><xref ref-type="bibr" rid="bibr101-0194599813477837"/><xref ref-type="bibr" rid="bibr102-0194599813477837"/><xref ref-type="bibr" rid="bibr103-0194599813477837"/><xref ref-type="bibr" rid="bibr104-0194599813477837"/><xref ref-type="bibr" rid="bibr105-0194599813477837"/><xref ref-type="bibr" rid="bibr106-0194599813477837"/><xref ref-type="bibr" rid="bibr107-0194599813477837"/><xref ref-type="bibr" rid="bibr108-0194599813477837"/>-<xref ref-type="bibr" rid="bibr109-0194599813477837">109</xref></sup></p>
<p>Although this exploratory review was limited to the English language and did not incorporate manual searches or expert opinion, it still remains a comprehensive assessment of the literature to date and highlights the multiple deficits that exist in this field. Without doubt, further research is required to fully delineate the exact relationship of several of these female physiological conditions with the rhinological manifestations presented. Future studies should ensure that adequate patient numbers are recruited to make their conclusions meaningful and ensure standardized definitions or diagnostic criteria are applied, especially in the area of pregnancy rhinitis. A more stringent study design in terms of adequate controlling for conditions affecting nasal physiology such as smoking plus ensuring adequate numbers in control groups would help to resolve many of the unanswered questions in this interesting field.</p>
</sec>
<sec id="section41-0194599813477837">
<title>Author Contributions</title>
<p><bold>Alexander J. Saxby</bold>, read and analyzed all papers in review and wrote paper; <bold>Pia Pace-Asciak</bold>, read and analyzed all studies in systematic review and gave oral presentation at AAO-HNSF meeting; <bold>Rachelle C. Dar Santos</bold>, involved in study design and acquisition of all studies to be reviewed and critical appraisal of drafted report; <bold>Neil K. Chadha</bold>, involved in study design and critical appraisal of drafted report; <bold>Frederick K. Kozak</bold>, involved in study design and selected all titles for full reference review and critical appraisal of drafted report.</p>
</sec>
<sec id="section42-0194599813477837">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<ack>
<p>We thank the senior librarian, Karen MacDonell, at the College of Physicians and Surgeons of British Columbia Library for her assistance with creating a search protocol for this study.</p>
</ack>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
<p>This article was presented at the 2012 AAO-HNSF Annual Meeting &amp; OTO EXPO; September 9-12, 2012; Washington, DC.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599813477837">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moher</surname><given-names>D</given-names></name>
<name><surname>Liberati</surname><given-names>A</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
</person-group>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>Ann Intern Med</source>. <year>2009</year>;<volume>151</volume>(<issue>4</issue>):<fpage>264</fpage>-<lpage>269</lpage>, <fpage>W264</fpage>.</citation>
</ref>
<ref id="bibr2-0194599813477837">
<label>2.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Howick</surname><given-names>J</given-names></name>
<name><surname>Glasziou</surname><given-names>P</given-names></name>
<name><surname>Greenhalgh</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>The Oxford 2011 Levels of Evidence</article-title>. <year>2011</year>; <publisher-name>Oxford Centre for Evidence-Based Medicine</publisher-name>. <ext-link ext-link-type="uri" xlink:href="http://www.cebm.net/index.aspx?o=5653">http://www.cebm.net/index.aspx?o=5653</ext-link>
</citation>
</ref>
<ref id="bibr3-0194599813477837">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jadad</surname><given-names>AR</given-names></name>
<name><surname>Moore</surname><given-names>RA</given-names></name>
<name><surname>Carroll</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</article-title> <source>Control Clin Trials</source>. <year>1996</year>;<volume>17</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr4-0194599813477837">
<label>4.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Wells</surname><given-names>GA SB</given-names></name>
<name><surname>O’Connell</surname><given-names>D</given-names></name>
<name><surname>Peterson</surname><given-names>J</given-names></name>
<name><surname>Welch</surname><given-names>V</given-names></name>
<name><surname>Losos</surname><given-names>M</given-names></name>
</person-group>. <article-title>The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses</article-title>. <year>2009</year>. <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm">http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm</ext-link>
</citation>
</ref>
<ref id="bibr5-0194599813477837">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellegard</surname><given-names>EK</given-names></name>
<name><surname>Hellgren</surname><given-names>M</given-names></name>
<name><surname>Karlsson</surname><given-names>NG</given-names></name>
</person-group>. <article-title>Fluticasone propionate aqueous nasal spray in pregnancy rhinitis</article-title>. <source>Clin Otolaryngol</source>. <year>2001</year>;<volume>26</volume>(<issue>5</issue>):<fpage>394</fpage>-<lpage>400</lpage>.</citation>
</ref>
<ref id="bibr6-0194599813477837">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toll</surname><given-names>K</given-names></name>
<name><surname>Graf</surname><given-names>P</given-names></name>
</person-group>. <article-title>Phenylpropanolamine’s decongestive effect on the nasalmucosa of pregnant women with nasal stuffiness</article-title>. <source>Rhinology</source>. <year>2006</year>;<volume>44</volume>(<issue>4</issue>):<fpage>274</fpage>-<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr7-0194599813477837">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garavello</surname><given-names>W</given-names></name>
<name><surname>Somigliana</surname><given-names>E</given-names></name>
<name><surname>Acaia</surname><given-names>B</given-names></name>
<name><surname>Gaini</surname><given-names>L</given-names></name>
<name><surname>Pignataro</surname><given-names>L</given-names></name>
<name><surname>Gaini</surname><given-names>RM</given-names></name>
</person-group>. <article-title>Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study</article-title>. <source>Int Arch Allergy Immunol</source>. <year>2010</year>;<volume>151</volume>(<issue>2</issue>):<fpage>137</fpage>-<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr8-0194599813477837">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nappi</surname><given-names>C</given-names></name>
<name><surname>Di Spiezio Sardo</surname><given-names>A</given-names></name>
<name><surname>Guerra</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Comparison of intranasal and transdermal estradiol on nasal mucosa in postmenopausal women</article-title>. <source>Menopause</source>. <year>2004</year>;<volume>11</volume>(<issue>4</issue>):<fpage>447</fpage>-<lpage>455</lpage>.</citation>
</ref>
<ref id="bibr9-0194599813477837">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gilbert</surname><given-names>AN</given-names></name>
<name><surname>Wysocki</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>Quantitative assessment of olfactory experience during pregnancy</article-title>. <source>Psychosom Med</source>. <year>1991</year>;<volume>53</volume>(<issue>6</issue>):<fpage>693</fpage>-<lpage>700</lpage>.</citation>
</ref>
<ref id="bibr10-0194599813477837">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cameron</surname><given-names>EL</given-names></name>
</person-group>. <article-title>Measures of human olfactory perception during pregnancy</article-title>. <source>Chem Senses</source>. <year>2007</year>;<volume>32</volume>(<issue>8</issue>):<fpage>775</fpage>-<lpage>782</lpage>.</citation>
</ref>
<ref id="bibr11-0194599813477837">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ochsenbein-Kolble</surname><given-names>N</given-names></name>
<name><surname>von Mering</surname><given-names>R</given-names></name>
<name><surname>Zimmermann</surname><given-names>R</given-names></name>
<name><surname>Hummel</surname><given-names>T</given-names></name>
</person-group>. <article-title>Changes in olfactory function in pregnancy and postpartum</article-title>. <source>Int J Gynaecol Obstet</source>. <year>2007</year>;<volume>97</volume>(<issue>1</issue>):<fpage>10</fpage>-<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr12-0194599813477837">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kolble</surname><given-names>N</given-names></name>
<name><surname>Hummel</surname><given-names>T</given-names></name>
<name><surname>von Mering</surname><given-names>R</given-names></name>
<name><surname>Huch</surname><given-names>A</given-names></name>
<name><surname>Huch</surname><given-names>R</given-names></name>
</person-group>. <article-title>Gustatory and olfactory function in the first trimester of pregnancy</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2001</year>;<volume>99</volume>(<issue>2</issue>):<fpage>179</fpage>-<lpage>183</lpage>.</citation>
</ref>
<ref id="bibr13-0194599813477837">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wohlgemuth</surname><given-names>C</given-names></name>
<name><surname>Beinder</surname><given-names>E</given-names></name>
<name><surname>Ochsenbein-Kölblea</surname><given-names>N</given-names></name>
<name><surname>Hummel</surname><given-names>T</given-names></name>
</person-group>. <article-title>Changes in olfactory function with several pregnancies?</article-title> <source>Swiss Med Wkly</source>. <year>2008</year>;<volume>138</volume>(<issue>31-32</issue>):<fpage>466</fpage>-<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr14-0194599813477837">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cismaresco</surname><given-names>AS</given-names></name>
<name><surname>Bonnin</surname><given-names>F</given-names></name>
</person-group>. <article-title>Evolution of maternal mood state and of the auditory and olfactory perception of their newborn: preliminary data</article-title>. <source>J Psychosom Obstet Gynaecol</source>. <year>1993</year>;<volume>14</volume>(<issue>1</issue>):<fpage>65</fpage>-<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr15-0194599813477837">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cooksey</surname><given-names>NR</given-names></name>
</person-group>. <article-title>Pica and olfactory craving of pregnancy: how deep are the secrets?</article-title> <source>Birth</source>. <year>1995</year>;<volume>22</volume>(<issue>3</issue>):<fpage>129</fpage>-<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr16-0194599813477837">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Swallow</surname><given-names>BL</given-names></name>
<name><surname>Lindow</surname><given-names>SW</given-names></name>
<name><surname>Aye</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Smell perception during early pregnancy: no evidence of an adaptive mechanism</article-title>. <source>Br J Obstet Gynaecol</source>. <year>2005</year>;<volume>112</volume>(<issue>1</issue>):<fpage>57</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr17-0194599813477837">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Robinson</surname><given-names>AM</given-names></name>
<name><surname>Philpott</surname><given-names>CM</given-names></name>
<name><surname>Gaskin</surname><given-names>JA</given-names></name>
<name><surname>Wolstenholme</surname><given-names>CR</given-names></name>
<name><surname>Murty</surname><given-names>GE</given-names></name>
</person-group>. <article-title>The effect of female hormone manipulation on nasal physiology</article-title>. <source>Am J Rhinol</source>. <year>2007</year>;<volume>21</volume>(<issue>6</issue>):<fpage>675</fpage>-<lpage>679</lpage>.</citation>
</ref>
<ref id="bibr18-0194599813477837">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Olofsson</surname><given-names>JK</given-names></name>
<name><surname>Broman</surname><given-names>DA</given-names></name>
<name><surname>Wulff</surname><given-names>M</given-names></name>
<name><surname>Martinkauppi</surname><given-names>M</given-names></name>
<name><surname>Nordin</surname><given-names>S</given-names></name>
</person-group>. <article-title>Olfactory and chemosomatosensory function in pregnant women assessed with event-related potentials</article-title>. <source>Physiol Behav</source>. <year>2005</year>;<volume>86</volume>(<issue>1-2</issue>):<fpage>252</fpage>-<lpage>257</lpage>.</citation>
</ref>
<ref id="bibr19-0194599813477837">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hardy</surname><given-names>JJ</given-names></name>
<name><surname>Connolly</surname><given-names>CM</given-names></name>
<name><surname>Weir</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>Epistaxis in pregnancy—not to be sniffed at!</article-title> <source>Int J Obstet Anesth</source>. <year>2008</year>;<volume>17</volume>(<issue>1</issue>):<fpage>94</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr20-0194599813477837">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Howard</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>Life-threatening epistaxis in pregnancy</article-title>. <source>J Laryngol Otol</source>. <year>1985</year>;<volume>99</volume>(<issue>1</issue>):<fpage>95</fpage>-<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr21-0194599813477837">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Poelmann</surname><given-names>AM</given-names></name>
<name><surname>Aarnoudse</surname><given-names>JG</given-names></name>
</person-group>. <article-title>A pregnant woman with severe epistaxis—a rare manifestation of folic acid deficiency</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>1986</year>;<volume>23</volume>(<issue>3-4</issue>):<fpage>249</fpage>-<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr22-0194599813477837">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aynaoglu</surname><given-names>G</given-names></name>
<name><surname>Durdag</surname><given-names>GD</given-names></name>
<name><surname>Ozmen</surname><given-names>B</given-names></name>
<name><surname>Soylemez</surname><given-names>F</given-names></name>
</person-group>. <article-title>Successful treatment of hereditary factor VII deficiency presented for the first time with epistaxis in pregnancy: a case report</article-title>. <source>J Matern Fetal Med</source>. <year>2010</year>;<volume>23</volume>(<issue>9</issue>):<fpage>1053</fpage>-<lpage>1055</lpage>.</citation>
</ref>
<ref id="bibr23-0194599813477837">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Braithwaite</surname><given-names>JM</given-names></name>
<name><surname>Economides</surname><given-names>DL</given-names></name>
</person-group>. <article-title>Severe recurrent epistaxis causing antepartum fetal distress</article-title>. <source>Int J Gynaecol Obstet</source>. <year>1995</year>;<volume>50</volume>(<issue>2</issue>):<fpage>197</fpage>-<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr24-0194599813477837">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klein</surname><given-names>ML</given-names></name>
<name><surname>Cochran-Black</surname><given-names>DL</given-names></name>
</person-group>. <article-title>Easy bruising and epistaxis in a 30-year-old pregnant woman</article-title>. <source>Lab Med</source>. <year>2004</year>;<volume>35</volume>(<issue>6</issue>):<fpage>357</fpage>-<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr25-0194599813477837">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dugan-Kim</surname><given-names>M</given-names></name>
<name><surname>Connell</surname><given-names>S</given-names></name>
<name><surname>Stika</surname><given-names>C</given-names></name>
<name><surname>Wong</surname><given-names>CA</given-names></name>
<name><surname>Gossett</surname><given-names>DR</given-names></name>
</person-group>. <article-title>Epistaxis of pregnancy and association with postpartum hemorrhage</article-title>. <source>Obstet Gynecol</source>. <year>2009</year>;<volume>114</volume>(<issue>6</issue>):<fpage>1322</fpage>-<lpage>1325</lpage>.</citation>
</ref>
<ref id="bibr26-0194599813477837">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bende</surname><given-names>M</given-names></name>
<name><surname>Gredmark</surname><given-names>T</given-names></name>
</person-group>. <article-title>Nasal stuffiness during pregnancy</article-title>. <source>Laryngoscope</source>. <year>1999</year>;<volume>109</volume>(<issue>7</issue>, <supplement>pt 1</supplement>):<fpage>1108</fpage>-<lpage>1110</lpage>.</citation>
</ref>
<ref id="bibr27-0194599813477837">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellegard</surname><given-names>E</given-names></name>
<name><surname>Hellgren</surname><given-names>M</given-names></name>
<name><surname>Toren</surname><given-names>K</given-names></name>
<name><surname>Karlsson</surname><given-names>G</given-names></name>
</person-group>. <article-title>The incidence of pregnancy rhinitis</article-title>. <source>Gynecol Obstet Invest</source>. <year>2000</year>;<volume>49</volume>(<issue>2</issue>):<fpage>98</fpage>-<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr28-0194599813477837">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellegard</surname><given-names>E</given-names></name>
<name><surname>Karlsson</surname><given-names>G</given-names></name>
</person-group>. <article-title>Nasal congestion during pregnancy</article-title>. <source>Clin Otolaryngol</source>. <year>1999</year>;<volume>24</volume>(<issue>4</issue>):<fpage>307</fpage>-<lpage>311</lpage>.</citation>
</ref>
<ref id="bibr29-0194599813477837">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellegard</surname><given-names>E</given-names></name>
<name><surname>Karlsson</surname><given-names>G</given-names></name>
</person-group>. <article-title>IgE-mediated reactions and hyperreactivity in pregnancy rhinitis</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>1999</year>;<volume>125</volume>(<issue>10</issue>):<fpage>1121</fpage>-<lpage>1125</lpage>.</citation>
</ref>
<ref id="bibr30-0194599813477837">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellegard</surname><given-names>EK</given-names></name>
<name><surname>Karlsson</surname><given-names>NG</given-names></name>
</person-group>. <article-title>Nasal mucociliary transport in pregnancy</article-title>. <source>Am J Rhinol</source>. <year>2000</year>;<volume>14</volume>(<issue>6</issue>):<fpage>375</fpage>-<lpage>378</lpage>.</citation>
</ref>
<ref id="bibr31-0194599813477837">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellegard</surname><given-names>E</given-names></name>
<name><surname>Oscarsson</surname><given-names>J</given-names></name>
<name><surname>Bougoussa</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Serum level of placental growth hormone is raised in pregnancy rhinitis</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>1998</year>;<volume>124</volume>(<issue>4</issue>):<fpage>439</fpage>-<lpage>443</lpage>.</citation>
</ref>
<ref id="bibr32-0194599813477837">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shushan</surname><given-names>S</given-names></name>
<name><surname>Sadan</surname><given-names>O</given-names></name>
<name><surname>Lurie</surname><given-names>S</given-names></name>
<name><surname>Evron</surname><given-names>S</given-names></name>
<name><surname>Golan</surname><given-names>A</given-names></name>
<name><surname>Roth</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Pregnancy-associated rhinitis</article-title>. <source>Am J Perinatol</source>. <year>2006</year>;<volume>23</volume>(<issue>7</issue>):<fpage>431</fpage>-<lpage>433</lpage>.</citation>
</ref>
<ref id="bibr33-0194599813477837">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rambur</surname><given-names>B</given-names></name>
</person-group>. <article-title>Pregnancy rhinitis and rhinitis medicamentosa</article-title>. <source>J Am Acad Nurse Pract</source>. <year>2002</year>;<volume>14</volume>(<issue>12</issue>):<fpage>527</fpage>-<lpage>530</lpage>.</citation>
</ref>
<ref id="bibr34-0194599813477837">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turnbull</surname><given-names>GL</given-names></name>
<name><surname>Rundell</surname><given-names>OH</given-names></name>
<name><surname>Rayburn</surname><given-names>WF</given-names></name>
<name><surname>Jones</surname><given-names>RK</given-names></name>
<name><surname>Pearman</surname><given-names>CS</given-names></name>
</person-group>. <article-title>Managing pregnancy-related nocturnal nasal congestion: the external nasal dilator</article-title>. <source>J Reprod Med</source>. <year>1996</year>;<volume>41</volume>(<issue>12</issue>):<fpage>897</fpage>-<lpage>902</lpage>.</citation>
</ref>
<ref id="bibr35-0194599813477837">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mabry</surname><given-names>RL</given-names></name>
</person-group>. <article-title>Rhinitis of pregnancy</article-title>. <source>South Med J</source>. <year>1986</year>;<volume>79</volume>(<issue>8</issue>):<fpage>965</fpage>-<lpage>971</lpage>.</citation>
</ref>
<ref id="bibr36-0194599813477837">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sobol</surname><given-names>SE</given-names></name>
<name><surname>Frenkiel</surname><given-names>S</given-names></name>
<name><surname>Nachtigal</surname><given-names>D</given-names></name>
<name><surname>Wiener</surname><given-names>D</given-names></name>
<name><surname>Teblum</surname><given-names>C</given-names></name>
</person-group>. <article-title>Clinical manifestations of sinonasal pathology during pregnancy</article-title>. <source>J Otolaryngol</source>. <year>2001</year>;<volume>30</volume>(<issue>1</issue>):<fpage>24</fpage>-<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr37-0194599813477837">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bende</surname><given-names>M</given-names></name>
<name><surname>Hallgarde</surname><given-names>M</given-names></name>
<name><surname>Sjogren</surname><given-names>U</given-names></name>
<name><surname>Uvnas-Moberg</surname><given-names>K</given-names></name>
</person-group>. <article-title>Nasal congestion during pregnancy</article-title>. <source>Clin Otolaryngol</source>. <year>1989</year>;<volume>14</volume>(<issue>5</issue>):<fpage>385</fpage>-<lpage>387</lpage>.</citation>
</ref>
<ref id="bibr38-0194599813477837">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toppozada</surname><given-names>H</given-names></name>
<name><surname>Michaels</surname><given-names>L</given-names></name>
<name><surname>Toppozada</surname><given-names>M</given-names></name>
<name><surname>El-Ghazzawi</surname><given-names>I</given-names></name>
<name><surname>Talaat</surname><given-names>M</given-names></name>
<name><surname>Elwany</surname><given-names>S</given-names></name>
</person-group>. <article-title>The human respiratory nasal mucosa in pregnancy: an electron microscopic and histochemical study</article-title>. <source>J Laryngol Otol</source>. <year>1982</year>;<volume>96</volume>(<issue>7</issue>):<fpage>613</fpage>-<lpage>626</lpage>.</citation>
</ref>
<ref id="bibr39-0194599813477837">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abraham</surname><given-names>CM</given-names></name>
<name><surname>Ownby</surname><given-names>DR</given-names></name>
<name><surname>Peterson</surname><given-names>EL</given-names></name>
<etal/>
</person-group>. <article-title>The relationship between seroatopy and symptoms of either allergic rhinitis or asthma</article-title>. <source>J Allergy Clin Immunol</source>. <year>2007</year>;<volume>119</volume>(<issue>5</issue>):<fpage>1099</fpage>-<lpage>1104</lpage>.</citation>
</ref>
<ref id="bibr40-0194599813477837">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levin</surname><given-names>TA</given-names></name>
<name><surname>Ownby</surname><given-names>DR</given-names></name>
<name><surname>Smith</surname><given-names>PH</given-names></name>
<etal/>
</person-group>. <article-title>Relationship between extremely low total serum IgE levels and rhinosinusitis</article-title>. <source>Ann Allergy Asthma Immunol</source>. <year>2006</year>;<volume>97</volume>(<issue>5</issue>):<fpage>650</fpage>-<lpage>652</lpage>.</citation>
</ref>
<ref id="bibr41-0194599813477837">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauchau</surname><given-names>V</given-names></name>
<name><surname>Durham</surname><given-names>SR</given-names></name>
</person-group>. <article-title>Prevalence and rate of diagnosis of allergic rhinitis in Europe</article-title>. <source>Eur Respir J</source>. <year>2004</year>;<volume>24</volume>(<issue>5</issue>):<fpage>758</fpage>-<lpage>764</lpage>.</citation>
</ref>
<ref id="bibr42-0194599813477837">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tanaka</surname><given-names>K</given-names></name>
<name><surname>Miyake</surname><given-names>Y</given-names></name>
<name><surname>Arakawa</surname><given-names>M</given-names></name>
</person-group>. <article-title>Smoking and prevalence of allergic disorders in Japanese pregnant women: baseline data from the Kyushu Okinawa Maternal and Child Health Study</article-title>. <source>Environ Health</source>. <year>2012</year>;<volume>11</volume>:<fpage>15</fpage>.</citation>
</ref>
<ref id="bibr43-0194599813477837">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miyake</surname><given-names>Y</given-names></name>
<name><surname>Tanaka</surname><given-names>K</given-names></name>
<name><surname>Okubo</surname><given-names>H</given-names></name>
<name><surname>Sasaki</surname><given-names>S</given-names></name>
<name><surname>Arakawa</surname><given-names>M</given-names></name>
</person-group>. <article-title>Dietary meat and fat intake and prevalence of rhinoconjunctivitis in pregnant Japanese women: baseline data from the Kyushu Okinawa Maternal and Child Health Study</article-title>. <source>Nutr J</source>. <year>2012</year>;<volume>11</volume>:<fpage>19</fpage>.</citation>
</ref>
<ref id="bibr44-0194599813477837">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harris</surname><given-names>JM</given-names></name>
<name><surname>White</surname><given-names>C</given-names></name>
<name><surname>Moffat</surname><given-names>S</given-names></name>
<name><surname>Mills</surname><given-names>P</given-names></name>
<name><surname>Newman Taylor</surname><given-names>AJ</given-names></name>
<name><surname>Cullinan</surname><given-names>P</given-names></name>
</person-group>. <article-title>New pregnancies and loss of allergy</article-title>. <source>Clin Exper Allergy</source>. <year>2004</year>;<volume>34</volume>(<issue>3</issue>):<fpage>369</fpage>-<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr45-0194599813477837">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kircher</surname><given-names>S</given-names></name>
<name><surname>Schatz</surname><given-names>M</given-names></name>
<name><surname>Long</surname><given-names>L</given-names></name>
</person-group>. <article-title>Variables affecting asthma course during pregnancy</article-title>. <source>Ann Allergy Asthma Immunol</source>. <year>2002</year>;<volume>89</volume>(<issue>5</issue>):<fpage>463</fpage>-<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr46-0194599813477837">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zussman</surname><given-names>BM</given-names></name>
</person-group>. <article-title>The pregnant patient with asthma and hay fever: perennial treatment</article-title>. <source>Postgrad Med</source>. <year>1966</year>;<volume>39</volume>(<issue>4</issue>):<fpage>374</fpage>-<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr47-0194599813477837">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bellizzi</surname><given-names>R</given-names></name>
<name><surname>Drobotij</surname><given-names>E</given-names></name>
<name><surname>Keller</surname><given-names>D</given-names></name>
<name><surname>Kenevan</surname><given-names>R</given-names></name>
</person-group>. <article-title>Sinusitis secondary to pregnancy rhinitis, mimicking pain of endodontic origin: a case report</article-title>. <source>J Endodontics</source>. <year>1983</year>;<volume>9</volume>(<issue>2</issue>):<fpage>60</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr48-0194599813477837">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Demetri</surname><given-names>C</given-names></name>
<name><surname>Shoukri</surname><given-names>KC</given-names></name>
<name><surname>Taylor</surname><given-names>SL</given-names></name>
<name><surname>Silva</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Postpartum granulomatous hypophysitis with sphenoid sinus involvement: a case study</article-title>. <source>Endocr Pract</source>. <year>2010</year>;<volume>16</volume>(<issue>2</issue>):<fpage>264</fpage>-<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr49-0194599813477837">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Derber</surname><given-names>C</given-names></name>
<name><surname>Elam</surname><given-names>K</given-names></name>
<name><surname>Bearman</surname><given-names>G</given-names></name>
</person-group>. <article-title>Invasive sinonasal disease due to dematiaceous fungi in immunocompromised individuals: case report and review of the literature</article-title>. <source>Int J Infect Dis</source>. <year>2010</year>;<volume>14</volume>(<supplement>suppl 3</supplement>):<fpage>e329</fpage>-<lpage>e332</lpage>.</citation>
</ref>
<ref id="bibr50-0194599813477837">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wax</surname><given-names>JR</given-names></name>
<name><surname>Blackstone</surname><given-names>J</given-names></name>
<name><surname>Mancall</surname><given-names>A</given-names></name>
<name><surname>Cartin</surname><given-names>A</given-names></name>
<name><surname>Pinette</surname><given-names>MG</given-names></name>
</person-group>. <article-title>Sinogenic brain abscess complicating pregnancy</article-title>. <source>Am J Obstet Gynecol</source>. <year>2004</year>;<volume>191</volume>(<issue>5</issue>):<fpage>1711</fpage>-<lpage>1712</lpage>.</citation>
</ref>
<ref id="bibr51-0194599813477837">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rassekh</surname><given-names>CH</given-names></name>
<name><surname>Kinsella</surname><given-names>JB</given-names></name>
<name><surname>Calhoun</surname><given-names>KH</given-names></name>
<name><surname>Maggio</surname><given-names>WW</given-names></name>
<name><surname>Chaljub</surname><given-names>G</given-names></name>
<name><surname>Gourley</surname><given-names>WK</given-names></name>
</person-group>. <article-title>Skull base allergic fungal sinusitis with abducens palsy in the third trimester</article-title>. <source>Skull Base Surg</source>. <year>1996</year>;<volume>6</volume>(<issue>4</issue>):<fpage>253</fpage>-<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr52-0194599813477837">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pratt</surname><given-names>MF</given-names></name>
<name><surname>Burnett</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Fulminant Drechslera sinusitis in an immunocompetent host</article-title>. <source>Laryngoscope</source>. <year>1988</year>;<volume>98</volume>(<issue>12</issue>):<fpage>1343</fpage>-<lpage>1347</lpage>.</citation>
</ref>
<ref id="bibr53-0194599813477837">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Trivedi</surname><given-names>TH</given-names></name>
<name><surname>Jadhav</surname><given-names>DL</given-names></name>
<name><surname>Yeolekar</surname><given-names>ME</given-names></name>
<etal/>
</person-group>. <article-title>Rhinocerebral mucormycosis in a pregnant woman with diabetic ketoacidosis</article-title>. <source>J Assoc Physicians India</source>. <year>2002</year>;<volume>50</volume>:<fpage>592</fpage>-<lpage>594</lpage>.</citation>
</ref>
<ref id="bibr54-0194599813477837">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qader</surname><given-names>AMA</given-names></name>
<name><surname>Shaharuddin</surname><given-names>B</given-names></name>
<name><surname>Noor</surname><given-names>RAM</given-names></name>
<name><surname>Embong</surname><given-names>Z</given-names></name>
</person-group>. <article-title>Sudden visual loss in a pregnant woman</article-title>. <source>Int Med J</source>. <year>2007</year>;<volume>14</volume>(<issue>3</issue>):<fpage>225</fpage>-<lpage>227</lpage>.</citation>
</ref>
<ref id="bibr55-0194599813477837">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bicknell</surname><given-names>PG</given-names></name>
</person-group>. <article-title>Granulomata arising in the nasal mucosa during pregnancy</article-title>. <source>J Laryngol Otol</source>. <year>1971</year>;<volume>85</volume>(<issue>5</issue>):<fpage>515</fpage>-<lpage>520</lpage>.</citation>
</ref>
<ref id="bibr56-0194599813477837">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choudhary</surname><given-names>S</given-names></name>
<name><surname>MacKinnon</surname><given-names>CA</given-names></name>
<name><surname>Morrissey</surname><given-names>GP</given-names></name>
<name><surname>Tan</surname><given-names>ST</given-names></name>
</person-group>. <article-title>A case of giant nasal pyogenic granuloma gravidarum</article-title>. <source>J Craniofacial Surg</source>. <year>2005</year>;<volume>16</volume>(<issue>2</issue>):<fpage>319</fpage>-<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr57-0194599813477837">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hemani</surname><given-names>DD</given-names></name>
<name><surname>Gupta</surname><given-names>AK</given-names></name>
<name><surname>Sharma</surname><given-names>SD</given-names></name>
<name><surname>Sharma</surname><given-names>KK</given-names></name>
</person-group>. <article-title>Recurrent bilateral pregnancy granuloma of the nose</article-title>. <source>J Laryngol Otol</source>. <year>1981</year>;<volume>95</volume>(<issue>9</issue>):<fpage>957</fpage>-<lpage>960</lpage>.</citation>
</ref>
<ref id="bibr58-0194599813477837">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kitzmann</surname><given-names>AS</given-names></name>
<name><surname>Moore</surname><given-names>EJ</given-names></name>
<name><surname>Salomao</surname><given-names>DR</given-names></name>
<name><surname>Woog</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Cavernous hemangioma involving the lacrimal outflow system</article-title>. <source>Ophthal Plast Reconstr Surg</source>. <year>2007</year>;<volume>23</volume>(<issue>6</issue>):<fpage>488</fpage>-<lpage>490</lpage>.</citation>
</ref>
<ref id="bibr59-0194599813477837">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McShane</surname><given-names>DP</given-names></name>
<name><surname>Walsh</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Nasal granuloma gravidarum</article-title>. <source>J Laryngol Otol</source>. <year>1988</year>;<volume>102</volume>(<issue>9</issue>):<fpage>828</fpage>-<lpage>830</lpage>.</citation>
</ref>
<ref id="bibr60-0194599813477837">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Noorizan</surname><given-names>Y</given-names></name>
<name><surname>Salina</surname><given-names>H</given-names></name>
</person-group>. <article-title>Nasal septal haemangioma in pregnancy</article-title>. <source>Med J Malaysia</source>. <year>2010</year>;<volume>65</volume>(<issue>1</issue>):<fpage>70</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr61-0194599813477837">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Nasal granuloma gravidarum</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2002</year>;<volume>126</volume>(<issue>5</issue>):<fpage>591</fpage>-<lpage>592</lpage>.</citation>
</ref>
<ref id="bibr62-0194599813477837">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scott</surname><given-names>PM</given-names></name>
<name><surname>van Hasselt</surname><given-names>A</given-names></name>
</person-group>. <article-title>Case report of a bleeding nasal polyp during pregnancy</article-title>. <source>Ear Nose Throat J</source>. <year>1999</year>;<volume>78</volume>(<issue>8</issue>):<fpage>592</fpage>.</citation>
</ref>
<ref id="bibr63-0194599813477837">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Skau</surname><given-names>NK</given-names></name>
<name><surname>Pilgaard</surname><given-names>P</given-names></name>
<name><surname>Neilsen</surname><given-names>G</given-names></name>
</person-group>. <article-title>Granuloma gravidarum of the nasal mucous membrane</article-title>. <source>J Laryngol Otol</source>. <year>1987</year>;<volume>101</volume>(<issue>12</issue>):<fpage>1286</fpage>-<lpage>1288</lpage>.</citation>
</ref>
<ref id="bibr64-0194599813477837">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsu</surname><given-names>I-H</given-names></name>
<name><surname>Liao</surname><given-names>LJ</given-names></name>
<name><surname>Pei-Jen</surname><given-names>L</given-names></name>
<name><surname>Jin-Chung</surname><given-names>S</given-names></name>
</person-group>. <article-title>Pyogenic granuloma of the nasal cavity: an unusual complication of pregnancy</article-title>. <source>Taiwanese J Obstet Gynecol</source>. <year>2005</year>;<volume>44</volume>(<issue>1</issue>):<fpage>101</fpage>-<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr65-0194599813477837">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manus</surname><given-names>DA</given-names></name>
<name><surname>Sherbert</surname><given-names>D</given-names></name>
<name><surname>Jackson</surname><given-names>IT</given-names></name>
</person-group>. <article-title>Management considerations for the granuloma of pregnancy</article-title>. <source>Plast Reconstr Surg</source>. <year>1995</year>;<volume>95</volume>(<issue>6</issue>):<fpage>1045</fpage>-<lpage>1050</lpage>.</citation>
</ref>
<ref id="bibr66-0194599813477837">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jones</surname><given-names>JE</given-names></name>
<name><surname>Nguyen</surname><given-names>A</given-names></name>
<name><surname>Tabaee</surname><given-names>A</given-names></name>
</person-group>. <article-title>Pyogenic granuloma (pregnancy tumor) of the nasal cavity: a case report</article-title>. <source>J Reprod Med</source>. <year>2000</year>;<volume>45</volume>(<issue>9</issue>):<fpage>749</fpage>-<lpage>753</lpage>.</citation>
</ref>
<ref id="bibr67-0194599813477837">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kapella</surname><given-names>M</given-names></name>
<name><surname>Panosetti</surname><given-names>E</given-names></name>
<name><surname>Rombaux</surname><given-names>P</given-names></name>
<name><surname>Delos</surname><given-names>M</given-names></name>
<name><surname>Weynand</surname><given-names>B</given-names></name>
</person-group>. <article-title>Lobular capillary haemangioma of the nasal cavity: observation of three specific cases</article-title>. <source>Acta Otorhinolaryngol Belg</source>. <year>2001</year>;<volume>55</volume>(<issue>3</issue>):<fpage>241</fpage>-<lpage>246</lpage>.</citation>
</ref>
<ref id="bibr68-0194599813477837">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kent</surname><given-names>DL</given-names></name>
<name><surname>Fitzwater</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Nasal hemangioma of pregnancy</article-title>. <source>Ann Otol Rhinol Laryngol</source>. <year>1979</year>;<volume>88</volume>(<issue>3</issue>, <issue>pt 1</issue>):<fpage>331</fpage>-<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr69-0194599813477837">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lance</surname><given-names>E</given-names></name>
<name><surname>Schatz</surname><given-names>C</given-names></name>
<name><surname>Nach</surname><given-names>R</given-names></name>
<name><surname>Thomas</surname><given-names>P</given-names></name>
</person-group>. <article-title>Pyogenic granuloma gravidarum of the nasal fossa: CT features</article-title>. <source>J Comput Assist Tomogr</source>. <year>1992</year>;<volume>16</volume>(<issue>4</issue>):<fpage>663</fpage>-<lpage>664</lpage>.</citation>
</ref>
<ref id="bibr70-0194599813477837">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lim</surname><given-names>SJ</given-names></name>
<name><surname>Schleicher</surname><given-names>SM</given-names></name>
<name><surname>Milstein</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Granuloma pyogenicum (pregnancy tumor)</article-title>. <source>J Dermatol Surg Oncol</source>. <year>1989</year>;<volume>15</volume>(<issue>4</issue>):<volume>369</volume>, <fpage>472</fpage>.</citation>
</ref>
<ref id="bibr71-0194599813477837">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tantinikorn</surname><given-names>W</given-names></name>
<name><surname>Uiprasertkul</surname><given-names>M</given-names></name>
<name><surname>Assanasen</surname><given-names>P</given-names></name>
</person-group>. <article-title>Nasal granuloma gravidarum presenting with recurrent massive epistaxis</article-title>. <source>J Med Assoc Thai</source>. <year>2003</year>;<volume>86</volume>(<issue>5</issue>):<fpage>473</fpage>-<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr72-0194599813477837">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shallit</surname><given-names>JB</given-names></name>
<name><surname>Smith</surname><given-names>GA</given-names></name>
<name><surname>Francis</surname><given-names>D</given-names></name>
<name><surname>Canalis</surname><given-names>RF</given-names></name>
</person-group>. <article-title>Nasal hemangiomas of pregnancy</article-title>. <source>Ear Nose Throat J</source>. <year>1977</year>;<volume>56</volume>(<issue>9</issue>):<fpage>377</fpage>-<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr73-0194599813477837">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Delbrouck</surname><given-names>C</given-names></name>
<name><surname>Chamiec</surname><given-names>M</given-names></name>
<name><surname>Hassid</surname><given-names>S</given-names></name>
<name><surname>Ghanooni</surname><given-names>R</given-names></name>
</person-group>. <article-title>Lobular capillary haemangioma of the nasal cavity during pregnancy</article-title>. <source>J Laryngol Otol</source>. <year>2011</year>;<volume>125</volume>(<issue>9</issue>):<fpage>973</fpage>-<lpage>977</lpage>.</citation>
</ref>
<ref id="bibr74-0194599813477837">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoruk</surname><given-names>O</given-names></name>
<name><surname>Ucuncu</surname><given-names>H</given-names></name>
<name><surname>Gursan</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Sinonasal Burkitt lymphoma presenting as a nasal polyposis in a pregnant woman</article-title>. <source>J Craniofac Surg</source>. <year>2009</year>;<volume>20</volume>(<issue>4</issue>):<fpage>1059</fpage>-<lpage>1060</lpage>.</citation>
</ref>
<ref id="bibr75-0194599813477837">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saheeb</surname><given-names>BD</given-names></name>
<name><surname>Ojo</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Midline lethal granuloma complicating pregnancy: case report</article-title>. <source>East Afr Med J</source>. <year>2003</year>;<volume>80</volume>(<issue>7</issue>):<fpage>391</fpage>-<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr76-0194599813477837">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peloquin</surname><given-names>L</given-names></name>
<name><surname>Klossek</surname><given-names>JM</given-names></name>
<name><surname>Basso-Brusa</surname><given-names>F</given-names></name>
<name><surname>Gougeon</surname><given-names>JM</given-names></name>
<name><surname>Toffel</surname><given-names>PH</given-names></name>
<name><surname>Fontanel</surname><given-names>JP</given-names></name>
</person-group>. <article-title>A rare case of nasopharyngeal angiofibroma in a pregnant woman</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>1997</year>;<volume>117</volume>(<issue>6</issue>):<fpage>S111</fpage>-<lpage>S114</lpage>.</citation>
</ref>
<ref id="bibr77-0194599813477837">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guimerá Martín-Neda</surname><given-names>F</given-names></name>
<name><surname>García Bustínduy</surname><given-names>M</given-names></name>
<name><surname>Noda Cabrera</surname><given-names>A</given-names></name>
<name><surname>Sánchez González</surname><given-names>R</given-names></name>
<name><surname>García Montelongo</surname><given-names>R</given-names></name>
</person-group>. <article-title>A rapidly growing eccrine poroma in a pregnant woman</article-title>. <source>J Am Acad Dermatol</source>. <year>2004</year>;<volume>50</volume>(<issue>1</issue>):<fpage>124</fpage>-<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr78-0194599813477837">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dascalu</surname><given-names>C</given-names></name>
<name><surname>Chayen</surname><given-names>B</given-names></name>
<name><surname>Kaplan</surname><given-names>B</given-names></name>
<name><surname>Harel</surname><given-names>L</given-names></name>
</person-group>. <article-title>Olfactory neuroblastoma as acute postpartum depression</article-title>. <source>J Am Board Fam Pract</source>. <year>1998</year>;<volume>11</volume>(<issue>5</issue>):<fpage>414</fpage>-<lpage>416</lpage>.</citation>
</ref>
<ref id="bibr79-0194599813477837">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Regan</surname><given-names>EM</given-names></name>
<name><surname>Gibb</surname><given-names>DH</given-names></name>
<name><surname>Odell</surname><given-names>EW</given-names></name>
</person-group>. <article-title>Rapid growth of giant cell granuloma in pregnancy treated with calcitonin</article-title>. <source>Oral Surg Oral Med Oral Path Oral Rad Endod</source>. <year>2001</year>;<volume>92</volume>(<issue>5</issue>):<fpage>532</fpage>-<lpage>538</lpage>.</citation>
</ref>
<ref id="bibr80-0194599813477837">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alici</surname><given-names>S</given-names></name>
<name><surname>Bavbek</surname><given-names>SE</given-names></name>
<name><surname>Eralp</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>An atypical presentation of metastatic gestational choriocarcinoma with maxillary sinus and subcutaneous involvement: report of a case with literature review</article-title>. <source>J Balkan Union Oncol</source>. <year>2002</year>;<volume>7</volume>(<issue>4</issue>):<fpage>373</fpage>-<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr81-0194599813477837">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tangtrakul</surname><given-names>S</given-names></name>
<name><surname>Linasmita</surname><given-names>V</given-names></name>
<name><surname>Wilailak</surname><given-names>S</given-names></name>
<name><surname>Srisupandit</surname><given-names>S</given-names></name>
<name><surname>Bullangpoti</surname><given-names>S</given-names></name>
<name><surname>Ayudhya</surname><given-names>NI</given-names></name>
</person-group>. <article-title>An HIV-infected woman with choriocarcinoma presenting with a nasal mass</article-title>. <source>Gynecol Oncol</source>. <year>1998</year>;<volume>68</volume>(<issue>3</issue>):<fpage>304</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr82-0194599813477837">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alfhaily</surname><given-names>F</given-names></name>
<name><surname>Watts</surname><given-names>R</given-names></name>
<name><surname>Leather</surname><given-names>A</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis occurring de novo during pregnancy</article-title>. <source>Clin Exper Rheumatol</source>. <month>Jan-Feb</month> <year>2009</year>;<volume>27</volume>(<issue>1</issue> <supplement>Suppl 52</supplement>):<fpage>S86</fpage>-<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr83-0194599813477837">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Spencer</surname><given-names>CP</given-names></name>
<name><surname>Soon</surname><given-names>R</given-names></name>
<name><surname>Weston</surname><given-names>MJ</given-names></name>
<name><surname>Makanjuola</surname><given-names>D</given-names></name>
</person-group>. <article-title>Pregnancy complicated by Wegener’s granulomatosis</article-title>. <source>J Obstet Gynaecol</source>. <year>1995</year>;<volume>15</volume>(<issue>6</issue>):<fpage>387</fpage>-<lpage>388</lpage>.</citation>
</ref>
<ref id="bibr84-0194599813477837">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Talbot</surname><given-names>SF</given-names></name>
<name><surname>Main</surname><given-names>DM</given-names></name>
<name><surname>Levinson</surname><given-names>AI</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis: first report of a case with onset during pregnancy</article-title>. <source>Arthritis Rheum</source>. <month>Jan</month> <year>1984</year>;<volume>27</volume>(<issue>1</issue>):<fpage>109</fpage>-<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr85-0194599813477837">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Milford</surname><given-names>CA</given-names></name>
<name><surname>Bellini</surname><given-names>M</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis arising in pregnancy</article-title>. <source>J Laryngol Otol</source>. <year>1986</year>;<volume>100</volume>(<issue>4</issue>):<fpage>475</fpage>-<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr86-0194599813477837">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SY</given-names></name>
<name><surname>Linton</surname><given-names>JM</given-names></name>
<name><surname>Kolasinski</surname><given-names>SL</given-names></name>
</person-group>. <article-title>Successful treatment of new onset Wegener’s granulomatosis with IVIG (intravenous immunoglobulin) during pregnancy: a case report</article-title>. <source>Mod Rheumatol</source>. <year>2008</year>;<volume>18</volume>(<issue>2</issue>):<fpage>177</fpage>-<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr87-0194599813477837">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Palit</surname><given-names>J</given-names></name>
<name><surname>Clague</surname><given-names>RB</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis presenting during first trimester of pregnancy</article-title>. <source>Br J Rheumatol</source>. <year>1990</year>;<volume>29</volume>(<issue>5</issue>):<fpage>389</fpage>-<lpage>390</lpage>.</citation>
</ref>
<ref id="bibr88-0194599813477837">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dayoan</surname><given-names>ES</given-names></name>
<name><surname>Dimen</surname><given-names>LL</given-names></name>
<name><surname>Boylen</surname><given-names>CT</given-names></name>
</person-group>. <article-title>Successful treatment of Wegener’s granulomatosis during pregnancy: a case report and review of the medical literature</article-title>. <source>Chest</source>. <year>1998</year>;<volume>113</volume>(<issue>3</issue>):<fpage>836</fpage>-<lpage>838</lpage>.</citation>
</ref>
<ref id="bibr89-0194599813477837">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Luisiri</surname><given-names>P</given-names></name>
<name><surname>Lance</surname><given-names>NJ</given-names></name>
<name><surname>Curran</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis in pregnancy</article-title>. <source>Arthritis Rheum</source>. <year>1997</year>;<volume>40</volume>(<issue>7</issue>):<fpage>1354</fpage>-<lpage>1360</lpage>.</citation>
</ref>
<ref id="bibr90-0194599813477837">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Masterson</surname><given-names>R</given-names></name>
<name><surname>Pellicano</surname><given-names>R</given-names></name>
<name><surname>Bleasel</surname><given-names>K</given-names></name>
<name><surname>McMahon</surname><given-names>LP</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis in pregnancy: a novel approach to management</article-title>. <source>Am J Kidney Dis</source>. <year>2004</year>;<volume>44</volume>(<issue>4</issue>):<fpage>e68</fpage>-<lpage>e72</lpage>.</citation>
</ref>
<ref id="bibr91-0194599813477837">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zafar</surname><given-names>U</given-names></name>
<name><surname>Sany</surname><given-names>O</given-names></name>
<name><surname>Velmurugan</surname><given-names>U</given-names></name>
<name><surname>Kabukoba</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis in pregnancy: a multidisciplinary approach</article-title>. <source>J Obstet Gynaecol</source>. <year>2008</year>;<volume>28</volume>(<issue>5</issue>):<fpage>532</fpage>-<lpage>533</lpage>.</citation>
</ref>
<ref id="bibr92-0194599813477837">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barry</surname><given-names>C</given-names></name>
<name><surname>Davis</surname><given-names>S</given-names></name>
<name><surname>Garrard</surname><given-names>P</given-names></name>
<name><surname>Ferguson</surname><given-names>IT</given-names></name>
</person-group>. <article-title>Churg-Strauss disease: deterioration in a twin pregnancy. Successful outcome following treatment with corticosteroids and cyclophosphamide</article-title>. <source>Br J Obstet Gynaecol</source>. <year>1997</year>;<volume>104</volume>(<issue>6</issue>):<fpage>746</fpage>-<lpage>747</lpage>.</citation>
</ref>
<ref id="bibr93-0194599813477837">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sahni</surname><given-names>V</given-names></name>
<name><surname>Agarwal</surname><given-names>SK</given-names></name>
<name><surname>Singh</surname><given-names>NP</given-names></name>
<etal/>
</person-group>. <article-title>Successful pregnancy in untreated limited Wegener’s granulomatosis</article-title>. <source>Med J Malaysia</source>. <year>2005</year>;<volume>60</volume>(<issue>4</issue>):<fpage>492</fpage>-<lpage>494</lpage>.</citation>
</ref>
<ref id="bibr94-0194599813477837">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>K</given-names></name>
<name><surname>Stafford</surname><given-names>J</given-names></name>
<name><surname>Turner-Warwick</surname><given-names>M</given-names></name>
</person-group>. <article-title>Wegener’s granuloma complicating pregnancy</article-title>. <source>J Obstet Gynaecol Br Commonwealth</source>. <year>1970</year>;<volume>77</volume>(<issue>11</issue>):<fpage>1028</fpage>-<lpage>1030</lpage>.</citation>
</ref>
<ref id="bibr95-0194599813477837">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mackworth-Young</surname><given-names>CG</given-names></name>
<name><surname>Morgan</surname><given-names>SH</given-names></name>
<name><surname>Hughes</surname><given-names>GR</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis: onset during puerperium</article-title>. <source>Arthritis Rheum</source>. <year>1984</year>;<volume>27</volume>(<issue>11</issue>):<fpage>1314</fpage>-<lpage>1315</lpage>.</citation>
</ref>
<ref id="bibr96-0194599813477837">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Habib</surname><given-names>A</given-names></name>
<name><surname>MacKay</surname><given-names>K</given-names></name>
<name><surname>Abrons</surname><given-names>HL</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis complicating pregnancy: presentation of two patients and review of the literature</article-title>. <source>Clin Nephrol</source>. <year>1996</year>;<volume>46</volume>(<issue>5</issue>):<fpage>332</fpage>-<lpage>336</lpage>.</citation>
</ref>
<ref id="bibr97-0194599813477837">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ogasawara</surname><given-names>M</given-names></name>
<name><surname>Kajiura</surname><given-names>S</given-names></name>
<name><surname>Inagaki</surname><given-names>H</given-names></name>
<name><surname>Sasa</surname><given-names>H</given-names></name>
<name><surname>Aoki</surname><given-names>K</given-names></name>
<name><surname>Yagami</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Successful pregnancy in a Churg-Strauss syndrome patient with a history of intrauterine fetal death</article-title>. <source>Int Arch Allergy Immunol</source>. <year>1995</year>;<volume>108</volume>(<issue>2</issue>):<fpage>200</fpage>-<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr98-0194599813477837">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hiyama</surname><given-names>J</given-names></name>
<name><surname>Shiota</surname><given-names>Y</given-names></name>
<name><surname>Marukawa</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Churg-Strauss syndrome associated with pregnancy</article-title>. <source>Intern Med</source>. <year>2000</year>;<volume>39</volume>(<issue>11</issue>):<fpage>985</fpage>-<lpage>990</lpage>.</citation>
</ref>
<ref id="bibr99-0194599813477837">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lima</surname><given-names>F</given-names></name>
<name><surname>Buchanan</surname><given-names>N</given-names></name>
<name><surname>Froes</surname><given-names>L</given-names></name>
<name><surname>Kerslake</surname><given-names>S</given-names></name>
<name><surname>Khamashta</surname><given-names>MA</given-names></name>
<name><surname>Hughes</surname><given-names>GR</given-names></name>
</person-group>. <article-title>Pregnancy in granulomatous vasculitis</article-title>. <source>Ann Rheum Dis</source>. <year>1995</year>;<volume>54</volume>(<issue>7</issue>):<fpage>604</fpage>-<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr100-0194599813477837">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parnham</surname><given-names>AP</given-names></name>
<name><surname>Thatcher</surname><given-names>GN</given-names></name>
</person-group>. <article-title>Pregnancy and active Wegener granulomatosis</article-title>. <source>Aust N Z J Obstet Gynaecol</source>. <year>1996</year>;<volume>36</volume>(<issue>3</issue>):<fpage>361</fpage>-<lpage>363</lpage>.</citation>
</ref>
<ref id="bibr101-0194599813477837">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cormio</surname><given-names>G</given-names></name>
<name><surname>Cramarossa</surname><given-names>D</given-names></name>
<name><surname>Di Vagno</surname><given-names>G</given-names></name>
<name><surname>Masciandaro</surname><given-names>A</given-names></name>
<name><surname>Loverro</surname><given-names>G</given-names></name>
</person-group>. <article-title>Successful pregnancy in a patient with Churg-Strauss syndrome</article-title>. <source>Euro J Obstet Gynecol Reprod Biol</source>. <year>1995</year>;<volume>60</volume>(<issue>1</issue>):<fpage>81</fpage>-<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr102-0194599813477837">
<label>102.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fields</surname><given-names>CL</given-names></name>
<name><surname>Ossorio</surname><given-names>MA</given-names></name>
<name><surname>Roy</surname><given-names>TM</given-names></name>
<name><surname>Bunke</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis complicated by pregnancy: a case report</article-title>. <source>J Reprod Med</source>. <year>1991</year>;<volume>36</volume>(<issue>6</issue>):<fpage>463</fpage>-<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr103-0194599813477837">
<label>103.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>A</given-names></name>
<name><surname>Mohan</surname><given-names>A</given-names></name>
<name><surname>Gupta</surname><given-names>R</given-names></name>
<name><surname>Singal</surname><given-names>VK</given-names></name>
<name><surname>Garg</surname><given-names>OP</given-names></name>
</person-group>. <article-title>Relapse of Wegener’s granulomatosis in the first trimester of pregnancy: a case report</article-title>. <source>Br J Rheumatol</source>. <year>1998</year>;<volume>37</volume>(<issue>3</issue>):<fpage>331</fpage>-<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr104-0194599813477837">
<label>104.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koukoura</surname><given-names>O</given-names></name>
<name><surname>Mantas</surname><given-names>N</given-names></name>
<name><surname>Linardakis</surname><given-names>H</given-names></name>
<name><surname>Hajiioannou</surname><given-names>J</given-names></name>
<name><surname>Sifakis</surname><given-names>S</given-names></name>
</person-group>. <article-title>Successful term pregnancy in a patient with Wegener’s granulomatosis: case report and literature review</article-title>. <source>Fertil Steril</source>. <year>2008</year>;<volume>89</volume>(<issue>2</issue>):<fpage>457.e1</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr105-0194599813477837">
<label>105.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harber</surname><given-names>MA</given-names></name>
<name><surname>Tso</surname><given-names>A</given-names></name>
<name><surname>Taheri</surname><given-names>S</given-names></name>
<name><surname>Tuck</surname><given-names>SM</given-names></name>
<name><surname>Burns</surname><given-names>A</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis in pregnancy—the therapeutic dilemma</article-title>. <source>Nephrol Dial Transplant</source>. <year>1999</year>;<volume>14</volume>(<issue>7</issue>):<fpage>1789</fpage>-<lpage>1791</lpage>.</citation>
</ref>
<ref id="bibr106-0194599813477837">
<label>106.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woywodt</surname><given-names>A</given-names></name>
<name><surname>de Groot</surname><given-names>K</given-names></name>
<name><surname>Bahte</surname><given-names>S</given-names></name>
<name><surname>Schwarz</surname><given-names>A</given-names></name>
<name><surname>Haller</surname><given-names>H</given-names></name>
<name><surname>Haubitz</surname><given-names>M</given-names></name>
</person-group>. <article-title>Severe relapse of Wegener’s granulomatosis during the early postpartum period</article-title>. <source>Ann Rheum Dis</source>. <year>2006</year>;<volume>65</volume>(<issue>1</issue>):<fpage>137</fpage>.</citation>
</ref>
<ref id="bibr107-0194599813477837">
<label>107.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hot</surname><given-names>A</given-names></name>
<name><surname>Perard</surname><given-names>L</given-names></name>
<name><surname>Coppere</surname><given-names>B</given-names></name>
<name><surname>Simon</surname><given-names>M</given-names></name>
<name><surname>Bouhour</surname><given-names>F</given-names></name>
<name><surname>Ninet</surname><given-names>J</given-names></name>
</person-group>. <article-title>Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins during pregnancy</article-title>. <source>Clin Rheumatol</source>. <year>2007</year>;<volume>26</volume>(<issue>12</issue>):<fpage>2149</fpage>-<lpage>2151</lpage>.</citation>
</ref>
<ref id="bibr108-0194599813477837">
<label>108.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Priori</surname><given-names>R</given-names></name>
<name><surname>Tomassini</surname><given-names>M</given-names></name>
<name><surname>Magrini</surname><given-names>L</given-names></name>
<name><surname>Conti</surname><given-names>F</given-names></name>
<name><surname>Valesini</surname><given-names>G</given-names></name>
</person-group>. <article-title>Churg-Strauss syndrome during pregnancy after steroid withdrawal</article-title>. <source>Lancet</source>. <year>1998</year>;<volume>352</volume>(<issue>9140</issue>):<fpage>1599</fpage>-<lpage>1600</lpage>.</citation>
</ref>
<ref id="bibr109-0194599813477837">
<label>109.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Connolly</surname><given-names>JO</given-names></name>
<name><surname>Lanham</surname><given-names>JG</given-names></name>
<name><surname>Partridge</surname><given-names>MR</given-names></name>
</person-group>. <article-title>Fulminant pregnancy-related Churg-Strauss syndrome</article-title>. <source>Br J Rheumatol</source>. <year>1994</year>;<volume>33</volume>(<issue>8</issue>):<fpage>776</fpage>-<lpage>777</lpage>.</citation>
</ref>
<ref id="bibr110-0194599813477837">
<label>110.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Auzary</surname><given-names>C</given-names></name>
<name><surname>Huong</surname><given-names>DT</given-names></name>
<name><surname>Wechsler</surname><given-names>B</given-names></name>
<name><surname>Vauthier-Brouzes</surname><given-names>D</given-names></name>
<name><surname>Piette</surname><given-names>JC</given-names></name>
</person-group>. <article-title>Pregnancy in patients with Wegener’s granulomatosis: report of five cases in three women</article-title>. <source>Ann Rheum Dis</source>. <year>2000</year>;<volume>59</volume>(<issue>10</issue>):<fpage>800</fpage>-<lpage>804</lpage>.</citation>
</ref>
<ref id="bibr111-0194599813477837">
<label>111.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bellisai</surname><given-names>F</given-names></name>
<name><surname>Morozzi</surname><given-names>G</given-names></name>
<name><surname>Marcolongo</surname><given-names>R</given-names></name>
<name><surname>Galeazzi</surname><given-names>M</given-names></name>
</person-group>. <article-title>Pregnancy in Wegener’s granulomatosis: successful treatment with intravenous immunoglobulin</article-title>. <source>Clin Rheumatol</source>. <year>2004</year>;<volume>23</volume>(<issue>6</issue>):<fpage>533</fpage>-<lpage>535</lpage>.</citation>
</ref>
<ref id="bibr112-0194599813477837">
<label>112.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jwarah</surname><given-names>E</given-names></name>
<name><surname>Ashworth</surname><given-names>F</given-names></name>
</person-group>. <article-title>Wegener’s granulomatosis in pregnancy</article-title>. <source>J Obstet Gynaecol</source>. <year>2006</year>;<volume>26</volume>(<issue>4</issue>):<fpage>368</fpage>-<lpage>370</lpage>.</citation>
</ref>
<ref id="bibr113-0194599813477837">
<label>113.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biesenbach</surname><given-names>G</given-names></name>
<name><surname>Stoger</surname><given-names>H</given-names></name>
<name><surname>Zazgornik</surname><given-names>J</given-names></name>
</person-group>. <article-title>Successful pregnancy of twins in a renal transplant patient with Wegener’s granulomatosis</article-title>. <source>Nephrol Dial Transplant</source>. <year>1991</year>;<volume>6</volume>(<issue>2</issue>):<fpage>139</fpage>-<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr114-0194599813477837">
<label>114.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Somogyi</surname><given-names>A</given-names></name>
<name><surname>Muzes</surname><given-names>G</given-names></name>
<name><surname>Molnar</surname><given-names>J</given-names></name>
<name><surname>Tulassay</surname><given-names>Z</given-names></name>
</person-group>. <article-title>Drug-related Churg-Strauss syndrome?</article-title> <source>Adverse Drug React Toxicol Rev</source>. <year>1998</year>;<volume>17</volume>(<issue>2-3</issue>):<fpage>63</fpage>-<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr115-0194599813477837">
<label>115.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Debby</surname><given-names>A</given-names></name>
<name><surname>Tanay</surname><given-names>A</given-names></name>
<name><surname>Zakut</surname><given-names>H</given-names></name>
</person-group>. <article-title>Allergic granulomatosis and angiitis (Churg-Strauss vasculitis) in pregnancy</article-title>. <source>Int Arch Allergy Immunol</source>. <year>1993</year>;<volume>102</volume>(<issue>3</issue>):<fpage>307</fpage>-<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr116-0194599813477837">
<label>116.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Corradi</surname><given-names>D</given-names></name>
<name><surname>Maestri</surname><given-names>R</given-names></name>
<name><surname>Facchetti</surname><given-names>F</given-names></name>
</person-group>. <article-title>Postpartum Churg-Strauss syndrome with severe cardiac involvement: description of a case and review of the literature</article-title>. <source>Clin Rheumatol</source>. <year>2009</year>;<volume>28</volume>(<issue>6</issue>):<fpage>739</fpage>-<lpage>743</lpage>.</citation>
</ref>
<ref id="bibr117-0194599813477837">
<label>117.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caruso</surname><given-names>S</given-names></name>
<name><surname>Grillo</surname><given-names>C</given-names></name>
<name><surname>Agnello</surname><given-names>C</given-names></name>
<name><surname>Maiolino</surname><given-names>L</given-names></name>
<name><surname>Intelisano</surname><given-names>G</given-names></name>
<name><surname>Serra</surname><given-names>A</given-names></name>
</person-group>. <article-title>A prospective study evidencing rhinomanometric and olfactometric outcomes in women taking oral contraceptives</article-title>. <source>Hum Reprod</source>. <year>2001</year>;<volume>16</volume>(<issue>11</issue>):<fpage>2288</fpage>-<lpage>2294</lpage>.</citation>
</ref>
<ref id="bibr118-0194599813477837">
<label>118.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grillo</surname><given-names>C</given-names></name>
<name><surname>La Mantia</surname><given-names>I</given-names></name>
<name><surname>Triolo</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Rhinomanometric and olfactometric variations throughout the menstrual cycle</article-title>. <source>Ann Otol Rhinol Laryngol</source>. <year>2001</year>;<volume>110</volume>(<issue>8</issue>):<fpage>785</fpage>-<lpage>789</lpage>.</citation>
</ref>
<ref id="bibr119-0194599813477837">
<label>119.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doty</surname><given-names>RL</given-names></name>
<name><surname>Snyder</surname><given-names>PJ</given-names></name>
<name><surname>Huggins</surname><given-names>GR</given-names></name>
<name><surname>Lowry</surname><given-names>LD</given-names></name>
</person-group>. <article-title>Endocrine, cardiovascular, and psychological correlated of olfactory sensitivity changes during the human menstrual cycle</article-title>. <source>J Comp Physiol Psychol</source>. <year>1981</year>;<volume>95</volume>(<issue>1</issue>):<fpage>45</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr120-0194599813477837">
<label>120.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vierling</surname><given-names>JS</given-names></name>
<name><surname>Rock</surname><given-names>J</given-names></name>
</person-group>. <article-title>Variations in olfactory sensitivity to exaltolide during the menstrual cycle</article-title>. <source>J Appl Physiol</source>. <year>1967</year>;<volume>22</volume>(<issue>2</issue>):<fpage>311</fpage>-<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr121-0194599813477837">
<label>121.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>K</given-names></name>
<name><surname>Umezu</surname><given-names>K</given-names></name>
<name><surname>Kurahashi</surname><given-names>T</given-names></name>
</person-group>. <article-title>Human olfactory contrast changes during the menstrual cycle</article-title>. <source>Jpn J Physiol</source>. <year>2002</year>;<volume>52</volume>(<issue>4</issue>):<fpage>353</fpage>-<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr122-0194599813477837">
<label>122.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Navarrete-Palacios</surname><given-names>E</given-names></name>
<name><surname>Hudson</surname><given-names>R</given-names></name>
<name><surname>Reyes-Guerrero</surname><given-names>G</given-names></name>
<name><surname>Guevara-Guzmán</surname><given-names>R</given-names></name>
</person-group>. <article-title>Lower olfactory threshold during the ovulatory phase of the menstrual cycle</article-title>. <source>Biol Psychol</source>. <year>2003</year>;<volume>63</volume>(<issue>3</issue>):<fpage>269</fpage>-<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr123-0194599813477837">
<label>123.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hummel</surname><given-names>T</given-names></name>
<name><surname>Gollisch</surname><given-names>R</given-names></name>
<name><surname>Wildt</surname><given-names>G</given-names></name>
<name><surname>Kobal</surname><given-names>G</given-names></name>
</person-group>. <article-title>Changes in olfactory perception during the menstrual cycle</article-title>. <source>Experientia</source>. <year>1991</year>;<volume>47</volume>(<issue>7</issue>):<fpage>712</fpage>-<lpage>715</lpage>.</citation>
</ref>
<ref id="bibr124-0194599813477837">
<label>124.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Purdon</surname><given-names>SE</given-names></name>
<name><surname>Klein</surname><given-names>S</given-names></name>
<name><surname>Flor-Henry</surname><given-names>P</given-names></name>
</person-group>. <article-title>Menstrual effects on asymmetrical olfactory acuity</article-title>. <source>J Int Neuropsychol Soc</source>. <year>2001</year>;<volume>7</volume>(<issue>6</issue>):<fpage>703</fpage>-<lpage>709</lpage>.</citation>
</ref>
<ref id="bibr125-0194599813477837">
<label>125.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mair</surname><given-names>RG</given-names></name>
<name><surname>Bouffard</surname><given-names>JA</given-names></name>
<name><surname>Engen</surname><given-names>T</given-names></name>
<name><surname>Morton</surname><given-names>TH</given-names></name>
</person-group>. <article-title>Olfactory sensitivity during the menstrual cycle</article-title>. <source>Sensory Processes</source>. <year>1978</year>;<volume>2</volume>(<issue>2</issue>):<fpage>90</fpage>-<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr126-0194599813477837">
<label>126.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pause</surname><given-names>BM</given-names></name>
<name><surname>Sojka</surname><given-names>B</given-names></name>
<name><surname>Krauel</surname><given-names>K</given-names></name>
<name><surname>Fehm-Wolfsdorf</surname><given-names>G</given-names></name>
<name><surname>Ferstl</surname><given-names>R</given-names></name>
</person-group>. <article-title>Olfactory information processing during the course of the menstrual cycle</article-title>. <source>Biol Psychol</source>. <year>1996</year>;<volume>44</volume>(<issue>1</issue>):<fpage>31</fpage>-<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr127-0194599813477837">
<label>127.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Man</surname><given-names>A</given-names></name>
<name><surname>Segal</surname><given-names>S</given-names></name>
</person-group>. <article-title>Epistaxis secondary to oral contraceptive</article-title>. <source>Acta Otolaryngol</source>. <year>1981</year>;<volume>92</volume>(<issue>3-4</issue>):<fpage>383</fpage>-<lpage>384</lpage>.</citation>
</ref>
<ref id="bibr128-0194599813477837">
<label>128.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rowley</surname><given-names>PT</given-names></name>
<name><surname>Kurnick</surname><given-names>J</given-names></name>
<name><surname>Cheville</surname><given-names>R</given-names></name>
</person-group>. <article-title>Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives?</article-title> <source>Lancet</source>. <year>1970</year>;<volume>1</volume>(<issue>7644</issue>):<fpage>474</fpage>-<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr129-0194599813477837">
<label>129.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Svanes</surname><given-names>C</given-names></name>
<name><surname>Real</surname><given-names>FG</given-names></name>
<name><surname>Gislason</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Association of asthma and hay fever with irregular menstruation</article-title>. <source>Thorax</source>. <year>2005</year>;<volume>60</volume>(<issue>6</issue>):<fpage>445</fpage>-<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr130-0194599813477837">
<label>130.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kljakovic</surname><given-names>M</given-names></name>
<name><surname>Pullon</surname><given-names>S</given-names></name>
</person-group>. <article-title>Allergy and the premenstrual syndrome (PMS)</article-title>. <source>Allergy</source>. <year>1997</year>;<volume>52</volume>(<issue>6</issue>):<fpage>681</fpage>-<lpage>683</lpage>.</citation>
</ref>
<ref id="bibr131-0194599813477837">
<label>131.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Driver</surname><given-names>HS</given-names></name>
<name><surname>McLean</surname><given-names>H</given-names></name>
<name><surname>Kumar</surname><given-names>DV</given-names></name>
<name><surname>Farr</surname><given-names>N</given-names></name>
<name><surname>Day</surname><given-names>AG</given-names></name>
<name><surname>Fitzpatrick</surname><given-names>MF</given-names></name>
</person-group>. <article-title>The influence of the menstrual cycle on upper airway resistance and breathing during sleep</article-title>. <source>Sleep</source>. <year>2005</year>;<volume>28</volume>(<issue>4</issue>):<fpage>449</fpage>-<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr132-0194599813477837">
<label>132.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Philpott</surname><given-names>CM</given-names></name>
<name><surname>El-Alami</surname><given-names>M</given-names></name>
<name><surname>Murty</surname><given-names>GE</given-names></name>
</person-group>. <article-title>The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle</article-title>. <source>Clin Otolaryngol</source>. <year>2004</year>;<volume>29</volume>(<issue>2</issue>):<fpage>138</fpage>-<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr133-0194599813477837">
<label>133.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haeggstrom</surname><given-names>A</given-names></name>
<name><surname>Ostberg</surname><given-names>B</given-names></name>
<name><surname>Stjerna</surname><given-names>P</given-names></name>
<name><surname>Graf</surname><given-names>P</given-names></name>
<name><surname>Hallen</surname><given-names>H</given-names></name>
</person-group>. <article-title>Nasal mucosal swelling and reactivity during a menstrual cycle</article-title>. <source>ORL J Otorhinolaryngol Relat Spec</source>. <year>2000</year>;<volume>62</volume>(<issue>1</issue>):<fpage>39</fpage>-<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr134-0194599813477837">
<label>134.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellegard</surname><given-names>E</given-names></name>
<name><surname>Karlsson</surname><given-names>G</given-names></name>
</person-group>. <article-title>Nasal congestion during the menstrual cycle</article-title>. <source>Clin Otolaryngol</source>. <year>1994</year>;<volume>19</volume>(<issue>5</issue>):<fpage>400</fpage>-<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr135-0194599813477837">
<label>135.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Paulsson</surname><given-names>B</given-names></name>
<name><surname>Gredmark</surname><given-names>T</given-names></name>
<name><surname>Burian</surname><given-names>P</given-names></name>
<name><surname>Bende</surname><given-names>M</given-names></name>
</person-group>. <article-title>Nasal mucosal congestion during the menstrual cycle</article-title>. <source>J Laryngol Otol</source>. <year>1997</year>;<volume>111</volume>(<issue>4</issue>):<fpage>337</fpage>-<lpage>339</lpage>.</citation>
</ref>
<ref id="bibr136-0194599813477837">
<label>136.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolstenholme</surname><given-names>CR</given-names></name>
<name><surname>Philpott</surname><given-names>CM</given-names></name>
<name><surname>Oloto</surname><given-names>EJ</given-names></name>
<name><surname>Murty</surname><given-names>GE</given-names></name>
</person-group>. <article-title>Does the use of the combined oral contraceptive pill cause changes in the nasal physiology in young women?</article-title> <source>Am J Rhinol</source>. <year>2006</year>;<volume>20</volume>(<issue>2</issue>):<fpage>238</fpage>-<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr137-0194599813477837">
<label>137.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stubner</surname><given-names>UP</given-names></name>
<name><surname>Gruber</surname><given-names>D</given-names></name>
<name><surname>Berger</surname><given-names>UE</given-names></name>
<etal/>
</person-group>. <article-title>The influence of female sex hormones on nasal reactivity in seasonal allergic rhinitis</article-title>. <source>Allergy</source>. <year>1999</year>;<volume>54</volume>(<issue>8</issue>):<fpage>865</fpage>-<lpage>871</lpage>.</citation>
</ref>
<ref id="bibr138-0194599813477837">
<label>138.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Navarrete-Palacios</surname><given-names>E</given-names></name>
<name><surname>Hudson</surname><given-names>R</given-names></name>
<name><surname>Reyes-Guerrero</surname><given-names>G</given-names></name>
<name><surname>Guevara-Guzman</surname><given-names>R</given-names></name>
</person-group>. <article-title>Correlation between cytological characteristics of the nasal epithelium and the menstrual cycle</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2003</year>;<volume>129</volume>(<issue>4</issue>):<fpage>460</fpage>-<lpage>463</lpage>.</citation>
</ref>
<ref id="bibr139-0194599813477837">
<label>139.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toppozada</surname><given-names>H</given-names></name>
<name><surname>Toppozada</surname><given-names>M</given-names></name>
<name><surname>El-Ghazzawi</surname><given-names>I</given-names></name>
<name><surname>Elwany</surname><given-names>S</given-names></name>
</person-group>. <article-title>The human respiratory nasal mucosa in females using contraceptive pills: an ultramicroscopic and histochemical study</article-title>. <source>J Laryngol Otol</source>. <year>1984</year>;<volume>98</volume>(<issue>1</issue>):<fpage>43</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr140-0194599813477837">
<label>140.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hughes</surname><given-names>LF</given-names></name>
<name><surname>McAsey</surname><given-names>ME</given-names></name>
<name><surname>Donathan</surname><given-names>CL</given-names></name>
<name><surname>Smith</surname><given-names>T</given-names></name>
<name><surname>Coney</surname><given-names>P</given-names></name>
<name><surname>Struble</surname><given-names>RG</given-names></name>
</person-group>. <article-title>Effects of hormone replacement therapy on olfactory sensitivity: cross-sectional and longitudinal studies</article-title>. <source>Climacteric</source>. <year>2002</year>;<volume>5</volume>(<issue>2</issue>):<fpage>140</fpage>-<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr141-0194599813477837">
<label>141.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caruso</surname><given-names>S</given-names></name>
<name><surname>Serra</surname><given-names>A</given-names></name>
<name><surname>Grillo</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Prospective study evaluating olfactometric and rhinomanometric outcomes in postmenopausal women on 1 mg 17beta-estradiol and 2 mg drospirenone HT</article-title>. <source>Menopause</source>. <year>2008</year>;<volume>15</volume>(<issue>5</issue>):<fpage>967</fpage>-<lpage>972</lpage>.</citation>
</ref>
<ref id="bibr142-0194599813477837">
<label>142.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deems</surname><given-names>DA</given-names></name>
<name><surname>Doty</surname><given-names>RL</given-names></name>
<name><surname>Settle</surname><given-names>RG</given-names></name>
<etal/>
</person-group>. <article-title>Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>1991</year>;<volume>117</volume>(<issue>5</issue>):<fpage>519</fpage>-<lpage>528</lpage>.</citation>
</ref>
<ref id="bibr143-0194599813477837">
<label>143.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lange</surname><given-names>R</given-names></name>
<name><surname>Donathan</surname><given-names>CL</given-names></name>
<name><surname>Hughes</surname><given-names>LF</given-names></name>
</person-group>. <article-title>Assessing olfactory abilities with the University of Pennsylvania smell identification test: a Rasch scaling approach</article-title>. <source>J Alzheimer Dis</source>. <year>2002</year>;<volume>4</volume>(<issue>2</issue>):<fpage>77</fpage>-<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr144-0194599813477837">
<label>144.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sundermann</surname><given-names>E</given-names></name>
<name><surname>Gilbert</surname><given-names>PE</given-names></name>
<name><surname>Murphy</surname><given-names>C</given-names></name>
</person-group>. <article-title>Estrogen and performance in recognition memory for olfactory and visual stimuli in females diagnosed with Alzheimer’s disease</article-title>. <source>J Int Neuropsychol Soc</source>. <year>2006</year>;<volume>12</volume>(<issue>3</issue>):<fpage>400</fpage>-<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr145-0194599813477837">
<label>145.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kopala</surname><given-names>LC</given-names></name>
<name><surname>Good</surname><given-names>K</given-names></name>
<name><surname>Honer</surname><given-names>WG</given-names></name>
</person-group>. <article-title>Olfactory identification ability in pre- and postmenopausal women with schizophrenia</article-title>. <source>Biol Psychiatry</source>. <year>1995</year>;<volume>38</volume>(<issue>1</issue>):<fpage>57</fpage>-<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr146-0194599813477837">
<label>146.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lund</surname><given-names>VJ</given-names></name>
<name><surname>Preziosi</surname><given-names>P</given-names></name>
<name><surname>Hercberg</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Yearly incidence of rhinitis, nasal bleeding, and other nasal symptoms in mature women</article-title>. <source>Rhinology</source>. <year>2006</year>;<volume>44</volume>(<issue>1</issue>):<fpage>26</fpage>-<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr147-0194599813477837">
<label>147.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Albinana</surname><given-names>V</given-names></name>
<name><surname>Bernabeu-Herrero</surname><given-names>ME</given-names></name>
<name><surname>Zarrabeitia</surname><given-names>R</given-names></name>
<name><surname>Bernabeu</surname><given-names>C</given-names></name>
<name><surname>Botella</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells</article-title>. <source>Thromb Haemost</source>. <year>2010</year>;<volume>103</volume>(<issue>3</issue>):<fpage>525</fpage>-<lpage>534</lpage>.</citation>
</ref>
<ref id="bibr148-0194599813477837">
<label>148.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jarvis</surname><given-names>D</given-names></name>
<name><surname>Leynaert</surname><given-names>B</given-names></name>
</person-group>. <article-title>The association of asthma, atopy and lung function with hormone replacement therapy and surgical cessation of menstruation in a population-based sample of English women</article-title>. <source>Allergy</source>. <year>2008</year>;<volume>63</volume>(<issue>1</issue>):<fpage>95</fpage>-<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr149-0194599813477837">
<label>149.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gomez Real</surname><given-names>F</given-names></name>
<name><surname>Svanes</surname><given-names>C</given-names></name>
<name><surname>Bjornsson</surname><given-names>EH</given-names></name>
<etal/>
</person-group>. <article-title>Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey</article-title>. <source>Thorax</source>. <year>2006</year>;<volume>61</volume>(<issue>1</issue>):<fpage>34</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr150-0194599813477837">
<label>150.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nappi</surname><given-names>C</given-names></name>
</person-group>. <article-title>Functional and morphologic evaluation of the nasal mucosa before and after hormone therapy in postmenopausal women with nasal symptoms</article-title>. <source>Fertil Steril</source>. <year>2003</year>;<volume>80</volume>(<issue>3</issue>):<fpage>669</fpage>-<lpage>671</lpage>.</citation>
</ref>
<ref id="bibr151-0194599813477837">
<label>151.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wild</surname><given-names>DC</given-names></name>
<name><surname>Philpott</surname><given-names>CM</given-names></name>
<name><surname>Wolstenholme</surname><given-names>CR</given-names></name>
<name><surname>Murty</surname><given-names>GE</given-names></name>
</person-group>. <article-title>Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?</article-title> <source>J Laryngol Otol</source>. <year>2008</year>;<volume>122</volume>(<issue>7</issue>):<fpage>707</fpage>-<lpage>710</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>